You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Identification
NameAtenolol
Accession NumberDB00335  (APRD00172)
TypeSmall Molecule
GroupsApproved
DescriptionA cardioselective beta-adrenergic blocker possessing properties and potency similar to propranolol, but without a negative inotropic effect. [PubChem]
Structure
Thumb
Synonyms
1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol
2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide
4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide
Atenololum
External Identifiers Not Available
Approved Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Act Atenololtablet50 mgoralActavis Pharma Company2004-08-13Not applicableCanada
Act Atenololtablet100 mgoralActavis Pharma Company2004-08-13Not applicableCanada
Ag-atenololtablet50 mgoralAngita Pharma Inc.Not applicableNot applicableCanada
Ag-atenololtablet100 mgoralAngita Pharma Inc.Not applicableNot applicableCanada
Ag-atenololtablet25 mgoralAngita Pharma Inc.Not applicableNot applicableCanada
Atenololtablet100 mgoralMeliapharm Inc2011-04-082014-06-25Canada
Atenololtablet25 mgoralPro Doc Limitee2009-06-15Not applicableCanada
Atenololtablet100 mgoralSivem Pharmaceuticals Ulc1999-03-09Not applicableCanada
Atenololtablet25 mgoralSivem Pharmaceuticals Ulc2003-04-21Not applicableCanada
Atenololtablet25 mgoralMeliapharm Inc2011-04-082014-06-25Canada
Atenololtablet100 mgoralPro Doc Limitee1989-12-31Not applicableCanada
Atenololtablet50 mgoralIvax Pharmaceuticals IncorporatedNot applicableNot applicableCanada
Atenololtablet50 mgoralMeliapharm Inc2011-04-082014-06-25Canada
Atenololtablet50 mgoralPro Doc Limitee1989-12-31Not applicableCanada
Atenololtablet50 mgoralSivem Pharmaceuticals Ulc1999-09-03Not applicableCanada
Atenololtablet100 mgoralIvax Pharmaceuticals IncorporatedNot applicableNot applicableCanada
Atenolol - Tab 100mgtablet100 mgoralSchein Pharmaceutical Canada Inc.1996-09-052005-07-27Canada
Atenolol - Tab 50mgtablet50 mgoralSchein Pharmaceutical Canada Inc.1996-09-052005-07-27Canada
Atenolol Tablets 100mgtablet100 mgoralPrempharm Inc1996-12-302005-08-05Canada
Atenolol Tablets 50mgtablet50 mgoralPrempharm Inc1996-12-302005-08-05Canada
Atenolol Tablets, BPtablet50 mgoralFc Pharma Inc.1999-06-152000-11-15Canada
Atenolol Tablets, BPtablet100 mgoralFc Pharma Inc.1999-06-152000-11-15Canada
Ava-atenololtablet25 mgoralAvanstra Inc2011-09-152014-08-21Canada
Bci Atenololtablet100 mgoralBaker Cummins Inc2005-07-042009-09-21Canada
Bci Atenololtablet50 mgoralBaker Cummins Inc2005-07-042009-09-22Canada
Bio-atenololtablet100 mgoralBiomed Pharma2013-03-26Not applicableCanada
Bio-atenololtablet25 mgoralBiomed Pharma2013-03-26Not applicableCanada
Bio-atenololtablet50 mgoralBiomed Pharma2013-03-26Not applicableCanada
Dom-atenolol - 100mgtablet100 mgoralDominion Pharmacal1996-10-17Not applicableCanada
Dom-atenolol - 50mgtablet50 mgoralDominion Pharmacal1996-10-17Not applicableCanada
Ftp-atenololtablet100 mgoralFtp Pharmacal Inc.1998-10-092004-08-03Canada
Ftp-atenololtablet50 mgoralFtp Pharmacal Inc.1998-10-092004-08-03Canada
Ipg-atenololtablet25 mgoralInternational Pharmaceutical Generics LtdNot applicableNot applicableCanada
Ipg-atenololtablet50 mgoralInternational Pharmaceutical Generics LtdNot applicableNot applicableCanada
Ipg-atenololtablet100 mgoralInternational Pharmaceutical Generics LtdNot applicableNot applicableCanada
Jamp-atenololtablet25 mgoralJamp Pharma Corporation2011-06-09Not applicableCanada
Jamp-atenololtablet50 mgoralJamp Pharma Corporation2011-06-09Not applicableCanada
Jamp-atenololtablet100 mgoralJamp Pharma Corporation2011-06-09Not applicableCanada
Mar-atenololtablet50 mgoralMarcan Pharmaceuticals Inc2012-10-22Not applicableCanada
Mar-atenololtablet100 mgoralMarcan Pharmaceuticals Inc2012-10-22Not applicableCanada
Mar-atenololtablet25 mgoralMarcan Pharmaceuticals Inc2012-10-22Not applicableCanada
Med Atenolol - Tab 100mgtablet100 mgoralMedican Pharma Incorporated1996-07-302011-03-29Canada
Med Atenolol - Tab 50mgtablet50 mgoralMedican Pharma Incorporated1996-07-302011-03-29Canada
Mint-atenoltablet25 mgoralMint Pharmaceuticals Inc2011-06-13Not applicableCanada
Mint-atenoltablet50 mgoralMint Pharmaceuticals Inc2011-06-13Not applicableCanada
Mint-atenoltablet100 mgoralMint Pharmaceuticals Inc2011-06-13Not applicableCanada
Mylan-atenololtablet50 mgoralMylan Pharmaceuticals Ulc1995-12-31Not applicableCanada
Mylan-atenololtablet100 mgoralMylan Pharmaceuticals Ulc1995-12-31Not applicableCanada
Mylan-atenololtablet25 mgoralMylan Pharmaceuticals Ulc2007-12-13Not applicableCanada
Ntp-atenoltablet50 mgoralTeva Canada LimitedNot applicableNot applicableCanada
Ntp-atenoltablet100 mgoralTeva Canada LimitedNot applicableNot applicableCanada
Ntp-atenoltablet25 mgoralTeva Canada LimitedNot applicableNot applicableCanada
Nu-atenol Tab 100mgtablet100 mgoralNu Pharm Inc1990-12-312012-09-04Canada
Nu-atenol Tab 50mgtablet50 mgoralNu Pharm Inc1990-12-312012-09-04Canada
Orb-atenololtablet50 mgoralOrbus Pharma IncNot applicableNot applicableCanada
Orb-atenololtablet100 mgoralOrbus Pharma IncNot applicableNot applicableCanada
Penta-atenolol - 100mgtablet100 mgoralPentapharm Ltd.Not applicableNot applicableCanada
Penta-atenolol - 50mgtablet50 mgoralPentapharm Ltd.Not applicableNot applicableCanada
PMS-atenololtablet25 mgoralPharmascience Inc2002-11-28Not applicableCanada
PMS-atenololtablet50 mgoralPharmascience Inc1998-03-31Not applicableCanada
PMS-atenololtablet100 mgoralPharmascience Inc1998-03-31Not applicableCanada
Ran-atenololtablet50 mgoralRanbaxy Pharmaceuticals Canada Inc.2005-07-05Not applicableCanada
Ran-atenololtablet100 mgoralRanbaxy Pharmaceuticals Canada Inc.2005-07-05Not applicableCanada
Ran-atenololtablet25 mgoralRanbaxy Pharmaceuticals Canada Inc.2012-01-18Not applicableCanada
Ratio-atenololtablet100 mgoralTeva Canada Limited1995-12-31Not applicableCanada
Ratio-atenololtablet50 mgoralTeva Canada Limited1995-12-31Not applicableCanada
Riva-atenololtablet25 mgoralLaboratoire Riva Inc2006-07-12Not applicableCanada
Riva-atenolol 100 mgtablet100 mgoralLaboratoire Riva Inc2000-05-23Not applicableCanada
Riva-atenolol 50 mgtablet50 mgoralLaboratoire Riva Inc2000-05-23Not applicableCanada
Sandoz Atenololtablet100 mgoralSandoz Canada Incorporated2000-06-07Not applicableCanada
Sandoz Atenololtablet50 mgoralSandoz Canada Incorporated2000-06-07Not applicableCanada
Septa-atenololtablet25 mgoralSepta Pharmaceuticals Inc2011-07-07Not applicableCanada
Septa-atenololtablet50 mgoralSepta Pharmaceuticals Inc2011-07-07Not applicableCanada
Septa-atenololtablet100 mgoralSepta Pharmaceuticals Inc2011-07-07Not applicableCanada
Taro-atenolol Tab 100mgtablet100 mgoralTaro Pharmaceuticals Inc1993-12-311998-10-21Canada
Taro-atenolol Tab 50mgtablet50 mgoralTaro Pharmaceuticals Inc1993-12-311998-10-21Canada
Tenormintablet100 mg/1oralAstra Zeneca Pharmaceuticals Lp1990-09-01Not applicableUs
Tenormintablet50 mg/1oralALMATICA PHARMA INC.2015-04-15Not applicableUs
Tenormintablet50 mg/1oralAstra Zeneca Pharmaceuticals Lp1990-09-01Not applicableUs
Tenormintablet100 mg/1oralALMATICA PHARMA INC.2015-04-15Not applicableUs
Tenormintablet25 mg/1oralAstra Zeneca Pharmaceuticals Lp1991-02-01Not applicableUs
Tenormintablet25 mg/1oralALMATICA PHARMA INC.2015-04-15Not applicableUs
Tenormin 100mgtablet100 mgoralAstrazeneca Canada Inc1994-12-31Not applicableCanada
Tenormin 50mgtablet50 mgoralAstrazeneca Canada Inc1995-12-31Not applicableCanada
Teva-atenololtablet100 mgoralTeva Canada Limited1991-12-312015-07-24Canada
Teva-atenololtablet25 mgoralTeva Canada Limited2005-11-17Not applicableCanada
Teva-atenololtablet50 mgoralTeva Canada Limited1991-12-312015-07-24Canada
Approved Generic Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Apo-atenol Tab 100mgtablet100 mgoralApotex Inc1988-12-31Not applicableCanada
Apo-atenol Tab 50mgtablet50 mgoralApotex Inc1988-12-31Not applicableCanada
Atenololtablet100 mg/1oralSt Marys Medical Park Pharmacy2013-07-10Not applicableUs
Atenololtablet100 mg/1oralRanbaxy Pharmaceuticals Inc.2007-12-04Not applicableUs
Atenololtablet50 mg/1oralLake Erie Medical & Surgical Supply DBA Quality Care Products LLC2011-01-30Not applicableUs
Atenololtablet50 mg/1oralMed Vantx, Inc.1995-02-22Not applicableUs
Atenololtablet100 mg/1oralREMEDYREPACK INC.2011-06-06Not applicableUs
Atenololtablet50 mg/mgoralLegacy Pharmaceutical Packaging2005-10-08Not applicableUs
Atenololtablet100 mg/1oralMylan Institutional Inc.1997-07-23Not applicableUs
Atenololtablet50 mg/1oralPreferred Pharmaceuticals, Inc.2014-10-09Not applicableUs
Atenololtablet25 mg/1oralMutual Pharmaceutical Company, Inc.1997-07-30Not applicableUs
Atenololtablet50 mg/1oralCardinal Health2011-06-20Not applicableUs
Atenololtablet100 mg/1oralNcs Health Care Of Ky, Inc Dba Vangard Labs2012-04-30Not applicableUs
Atenololtablet50 mg/1oralBlenheim Pharmacal, Inc.2014-01-06Not applicableUs
Atenololtablet50 mg/1oralClinical Solutions Wholesale2007-12-04Not applicableUs
Atenololtablet50 mg/1oralDIRECT RX2015-01-01Not applicableUs
Atenololtablet50 mg/1oralSTAT Rx USA LLC2007-12-04Not applicableUs
Atenololtablet50 mg/1oralCadila Healthcare Limited2005-08-10Not applicableUs
Atenololtablet25 mg/1oralPd Rx Pharmaceuticals, Inc.1992-05-01Not applicableUs
Atenololtablet25 mg/1oralAphena Pharma Solutions Tennessee, Llc1992-05-01Not applicableUs
Atenololtablet25 mg/1oralLake Erie Medical & Surgical Supply DBA Quality Care Products LLC2012-04-18Not applicableUs
Atenololtablet25 mg/1oralNorthstar Rx LLC2009-11-102015-12-29Us
Atenololtablet50 mg/1oralREMEDYREPACK INC.2012-11-27Not applicableUs
Atenololtablet50 mg/1oralState of Florida DOH Central Pharmacy2009-07-01Not applicableUs
Atenololtablet50 mg/1oralTeva Pharmaceuticals USA Inc1995-02-22Not applicableUs
Atenololtablet25 mg/1oralMajor Pharmaceuticals2010-09-28Not applicableUs
Atenololtablet50 mg/1oralState of Florida DOH Central Pharmacy2009-07-01Not applicableUs
Atenololtablet100 mg/1oralPd Rx Pharmaceuticals, Inc.2007-12-04Not applicableUs
Atenololtablet100 mg/1oralSandoz Inc1991-09-17Not applicableUs
Atenololtablet25 mg/1oralPack Pharmaceuticals LLC2010-06-10Not applicableUs
Atenololtablet25 mg/1oralREMEDYREPACK INC.2015-12-10Not applicableUs
Atenololtablet25 mg/1oralReady Meds1992-05-01Not applicableUs
Atenololtablet25 mg/1oralAv Kare, Inc.2013-06-17Not applicableUs
Atenololtablet25 mg/1oralRed Pharm Drug Inc.2007-12-04Not applicableUs
Atenololtablet25 mg/1oralREMEDYREPACK INC.2011-08-10Not applicableUs
Atenololtablet100 mg/1oralPreferred Pharmaceutials Inc.2015-08-20Not applicableUs
Atenololtablet100 mg/1oralMed Health Pharma, LLC2011-01-20Not applicableUs
Atenololtablet50 mg/1oralIngenus Pharmaceuticals, LLC2011-01-30Not applicableUs
Atenololtablet25 mg/1oralH.J. Harkins Company, Inc.2007-12-04Not applicableUs
Atenololtablet100 mg/1oralPhysicians Total Care, Inc.1999-03-04Not applicableUs
Atenololtablet50 mg/1oralMylan Pharmaceuticals Inc.2013-02-18Not applicableUs
Atenololtablet25 mg/1oralBlenheim Pharmacal, Inc.2013-09-03Not applicableUs
Atenololtablet25 mg/1oralGolden State Medical Supply, Inc.2014-02-20Not applicableUs
Atenololtablet25 mg/1oralProficient Rx LP2004-11-16Not applicableUs
Atenololtablet25 mg/1oralAidarex Pharmaceuticals LLC2007-12-04Not applicableUs
Atenololtablet100 mg/1oralAurobindo Pharma Limited2007-10-31Not applicableUs
Atenololtablet50 mg/1oralREMEDYREPACK INC.2011-04-14Not applicableUs
Atenololtablet50 mg/1oralZydus Pharmaceuticals (USA) Inc.2005-10-08Not applicableUs
Atenololtablet50 mg/1oralREMEDYREPACK INC.2015-04-02Not applicableUs
Atenololtablet50 mg/1oralbryant ranch prepack2007-12-04Not applicableUs
Atenololtablet25 mg/1oralLake Erie Medical DBA Quality Care Products LLC1992-05-01Not applicableUs
Atenololtablet50 mg/1oralContract Pharmacy Services Pa2010-04-07Not applicableUs
Atenololtablet100 mg/1oralREMEDYREPACK INC.2011-07-13Not applicableUs
Atenololtablet25 mg/1oralPreferred Pharmaceuticals, Inc.2007-12-04Not applicableUs
Atenololtablet25 mg/1oralMylan Institutional Inc.1999-06-16Not applicableUs
Atenololtablet50 mg/1oralA S Medication Solutions2005-10-08Not applicableUs
Atenololtablet50 mg/1oralState of Florida DOH Central Pharmacy2009-07-01Not applicableUs
Atenololtablet25 mg/1oralCardinal Health2011-06-20Not applicableUs
Atenololtablet25 mg/1oralNcs Health Care Of Ky, Inc Dba Vangard Labs1992-05-01Not applicableUs
Atenololtablet25 mg/1oralAurolife Pharma LLC2011-06-20Not applicableUs
Atenololtablet100 mg/1oralClinical Solutions Wholesale2007-12-04Not applicableUs
Atenololtablet50 mg/1oralAmerican Health Packaging2004-08-04Not applicableUs
Atenololtablet25 mg/1oralRebel Distributors Corp.1995-07-19Not applicableUs
Atenololtablet100 mg/1oralCadila Healthcare Limited2005-08-10Not applicableUs
Atenololtablet100 mg/1oralPd Rx Pharmaceuticals, Inc.1991-09-17Not applicableUs
Atenololtablet50 mg/1oralAphena Pharma Solutions Tennessee, Llc1995-02-22Not applicableUs
Atenololtablet50 mg/1oralUnit Dose Services2007-12-04Not applicableUs
Atenololtablet50 mg/1oralNorthstar Rx LLC2009-11-102015-12-29Us
Atenololtablet25 mg/1oralREMEDYREPACK INC.2013-05-08Not applicableUs
Atenololtablet50 mg/1oralState of Florida DOH Central Pharmacy2014-11-01Not applicableUs
Atenololtablet100 mg/1oralTeva Pharmaceuticals USA Inc1995-02-17Not applicableUs
Atenololtablet50 mg/1oralBlenheim Pharmacal, Inc.2010-01-07Not applicableUs
Atenololtablet100 mg/1oralREMEDYREPACK INC.2011-09-29Not applicableUs
Atenololtablet25 mg/1oralAvera Mc Kennan Hospital2015-03-20Not applicableUs
Atenololtablet25 mg/1oralNorthwind Pharmaceuticals, LLC2014-06-24Not applicableUs
Atenololtablet25 mg/1oralState of Florida DOH Central Pharmacy2009-07-01Not applicableUs
Atenololtablet25 mg/1oralClinical Solutions Wholesale, Llc1992-05-01Not applicableUs
Atenololtablet25 mg/1oralSandoz Inc1992-05-01Not applicableUs
Atenololtablet50 mg/1oralPack Pharmaceuticals LLC2010-06-10Not applicableUs
Atenololtablet25 mg/1oralDIRECT RX2014-01-01Not applicableUs
Atenololtablet50 mg/1oralReady Meds1991-09-17Not applicableUs
Atenololtablet50 mg/1oralAv Kare, Inc.2013-06-17Not applicableUs
Atenololtablet100 mg/1oralRed Pharm Drug Inc.2007-12-04Not applicableUs
Atenololtablet50 mg/1oralAidarex Pharmaceuticals LLC2007-12-04Not applicableUs
Atenololtablet50 mg/1oralMed Vantx, Inc.2007-12-04Not applicableUs
Atenololtablet25 mg/1oralREMEDYREPACK INC.2011-04-25Not applicableUs
Atenololtablet100 mg/1oralZydus Pharmaceuticals (USA) Inc.2005-10-08Not applicableUs
Atenololtablet100 mg/1oralIngenus Pharmaceuticals, LLC2011-01-30Not applicableUs
Atenololtablet25 mg/1oralA S Medication Solutions2005-10-08Not applicableUs
Atenololtablet50 mg/1oralMutual Pharmaceutical Company, Inc.1993-03-30Not applicableUs
Atenololtablet25 mg/1oralPhysicians Total Care, Inc.1995-07-19Not applicableUs
Atenololtablet100 mg/1oralMylan Pharmaceuticals Inc.2013-02-18Not applicableUs
Atenololtablet25 mg/1oralBlenheim Pharmacal, Inc.2013-11-15Not applicableUs
Atenololtablet50 mg/1oralSt Marys Medical Park Pharmacy2007-12-04Not applicableUs
Atenololtablet25 mg/1oralRanbaxy Pharmaceuticals Inc.2007-12-04Not applicableUs
Atenololtablet50 mg/1oralAurolife Pharma LLC2011-06-20Not applicableUs
Atenololtablet25 mg/1oralREMEDYREPACK INC.2015-04-02Not applicableUs
Atenololtablet25 mg/1oralbryant ranch prepack2007-12-04Not applicableUs
Atenololtablet100 mg/1oralRebel Distributors Corp2007-12-04Not applicableUs
Atenololtablet50 mg/1oralContract Pharmacy Services Pa2011-01-30Not applicableUs
Atenololtablet25 mg/1oralREMEDYREPACK INC.2011-07-08Not applicableUs
Atenololtablet50 mg/1oralPreferred Pharmaceuticals, Inc.2007-12-04Not applicableUs
Atenololtablet25 mg/1oralMed Health Pharma, LLC2011-01-20Not applicableUs
Atenololtablet100 mg/1oralState of Florida DOH Central Pharmacy2009-07-01Not applicableUs
Atenololtablet25 mg/1oralPd Rx Pharmaceuticals, Inc.2007-12-04Not applicableUs
Atenololtablet25 mg/1oralSandoz Inc1992-05-01Not applicableUs
Atenololtablet25 mg/1oralBlenheim Pharmacal, Inc.2012-01-19Not applicableUs
Atenololtablet50 mg/1oralGolden State Medical Supply, Inc.2014-02-20Not applicableUs
Atenololtablet50 mg/1oralProficient Rx LP2007-12-04Not applicableUs
Atenololtablet50 mg/1oralRebel Distributors Corp.1991-12-27Not applicableUs
Atenololtablet25 mg/1oralAurobindo Pharma Limited2007-10-31Not applicableUs
Atenololtablet50 mg/1oralAphena Pharma Solutions Tennessee, Llc1993-03-30Not applicableUs
Atenololtablet100 mg/1oralAphena Pharma Solutions Tennessee, Llc1991-09-17Not applicableUs
Atenololtablet25 mg/1oralUnit Dose Services2010-06-10Not applicableUs
Atenololtablet100 mg/1oralNorthstar Rx LLC2009-11-102015-12-29Us
Atenololtablet50 mg/1oralREMEDYREPACK INC.2013-05-28Not applicableUs
Atenololtablet50 mg/1oralState of Florida DOH Central Pharmacy2014-11-01Not applicableUs
Atenololtablet25 mg/1oralTeva Pharmaceuticals USA Inc2004-11-16Not applicableUs
Atenololtablet25 mg/1oralTYA Pharmaceuticals2007-12-04Not applicableUs
Atenololtablet100 mg/1oralAv Kare, Inc.2013-06-17Not applicableUs
Atenololtablet100 mg/1oralRed Pharm Drug Inc.2007-12-04Not applicableUs
Atenololtablet50 mg/1oralLake Erie Medical DBA Quality Care Products LLC2010-05-24Not applicableUs
Atenololtablet25 mg/1oralMc Kesson Contract Packaging2011-10-03Not applicableUs
Atenololtablet50 mg/1oralNorthwind Pharmaceuticals, LLC2015-03-26Not applicableUs
Atenololtablet100 mg/1oralState of Florida DOH Central Pharmacy2009-07-01Not applicableUs
Atenololtablet50 mg/1oralClinical Solutions Wholesale, Llc1991-09-17Not applicableUs
Atenololtablet50 mg/1oralSandoz Inc1991-09-17Not applicableUs
Atenololtablet100 mg/1oralPack Pharmaceuticals LLC2010-06-10Not applicableUs
Atenololtablet50 mg/1oralDIRECT RX2014-01-01Not applicableUs
Atenololtablet25 mg/1oralSt Marys Medical Park Pharmacy2007-12-04Not applicableUs
Atenololtablet50 mg/1oralRanbaxy Pharmaceuticals Inc.2007-12-04Not applicableUs
Atenololtablet100 mg/1oralAidarex Pharmaceuticals LLC2007-12-04Not applicableUs
Atenololtablet50 mg/1oralMed Vantx, Inc.2009-11-10Not applicableUs
Atenololtablet50 mg/1oralREMEDYREPACK INC.2011-03-16Not applicableUs
Atenololtablet50 mg/1oralLegacy Pharmaceutical Packaging2007-12-04Not applicableUs
Atenololtablet50 mg/1oralMylan Institutional Inc.1997-07-24Not applicableUs
Atenololtablet100 mg/1oralUnit Dose Services2007-12-04Not applicableUs
Atenololtablet100 mg/1oralMutual Pharmaceutical Company, Inc.1993-03-30Not applicableUs
Atenololtablet100 mg/1oralCardinal Health2011-06-20Not applicableUs
Atenololtablet50 mg/1oralNcs Health Care Of Ky, Inc Dba Vangard Labs2013-02-18Not applicableUs
Atenololtablet100 mg/1oralBlenheim Pharmacal, Inc.2013-11-15Not applicableUs
Atenololtablet100 mg/1oralAurolife Pharma LLC2011-06-20Not applicableUs
Atenololtablet100 mg/1oralREMEDYREPACK INC.2015-06-12Not applicableUs
Atenololtablet100 mg/1oralbryant ranch prepack2007-12-04Not applicableUs
Atenololtablet50 mg/1oralRebel Distributors Corp2007-12-04Not applicableUs
Atenololtablet25 mg/1oralRed Pharm Drug Inc.2007-12-04Not applicableUs
Atenololtablet50 mg/1oralREMEDYREPACK INC.2011-08-10Not applicableUs
Atenololtablet100 mg/1oralPreferred Pharmaceuticals, Inc.2007-12-04Not applicableUs
Atenololtablet50 mg/1oralMed Health Pharma, LLC2011-01-20Not applicableUs
Atenololtablet100 mg/1oralState of Florida DOH Central Pharmacy2009-07-01Not applicableUs
Atenololtablet50 mg/1oralPd Rx Pharmaceuticals, Inc.2007-12-04Not applicableUs
Atenololtablet50 mg/1oralSandoz Inc1991-09-17Not applicableUs
Atenololtablet50 mg/1oralPhysicians Total Care, Inc.1995-04-24Not applicableUs
Atenololtablet25 mg/1oralMylan Pharmaceuticals Inc.2013-02-18Not applicableUs
Atenololtablet50 mg/1oralBlenheim Pharmacal, Inc.2010-10-21Not applicableUs
Atenololtablet100 mg/1oralGolden State Medical Supply, Inc.2014-02-20Not applicableUs
Atenololtablet50 mg/1oralProficient Rx LP1991-09-17Not applicableUs
Atenololtablet100 mg/1oralRebel Distributors Corp.1991-12-27Not applicableUs
Atenololtablet50 mg/1oralAurobindo Pharma Limited2007-10-31Not applicableUs
Atenololtablet25 mg/1oralAphena Pharma Solutions Tennessee, Llc2004-11-16Not applicableUs
Atenololtablet25 mg/1oralZydus Pharmaceuticals (USA) Inc.2005-10-08Not applicableUs
Atenololtablet25 mg/1oralIngenus Pharmaceuticals, LLC2011-01-30Not applicableUs
Atenololtablet50 mg/1oralREMEDYREPACK INC.2013-05-22Not applicableUs
Atenololtablet25 mg/1oralDIRECT RX2015-01-01Not applicableUs
Atenololtablet25 mg/1oralCadila Healthcare Limited2005-08-10Not applicableUs
Atenololtablet50 mg/1oralPd Rx Pharmaceuticals, Inc.1991-09-17Not applicableUs
Atenololtablet50 mg/1oralAphena Pharma Solutions Tennessee, Llc1991-09-17Not applicableUs
Atenololtablet100 mg/1oralLake Erie Medical DBA Quality Care Products LLC1991-09-17Not applicableUs
Atenololtablet50 mg/1oralMc Kesson Contract Packaging2011-12-28Not applicableUs
Atenololtablet50 mg/1oralREMEDYREPACK INC.2012-08-28Not applicableUs
Atenololtablet25 mg/1oralState of Florida DOH Central Pharmacy2009-07-01Not applicableUs
Atenololtablet25 mg/1oralClinical Solutions Wholesale2007-12-04Not applicableUs
Atenololtablet100 mg/1oralSandoz Inc1991-09-17Not applicableUs
Atenololtablet25 mg/1oralSTAT Rx USA LLC2007-12-04Not applicableUs
Approved Over the Counter ProductsNot Available
Unapproved/Other Products Not Available
International Brands
NameCompany
MyocordIvax
NormitenTeva
Brand mixtures
NameLabellerIngredients
Apo-atenidoneApotex Inc
Atenolol and ChlorthalidoneMylan Pharmaceuticals Inc.
Atenolol ScopolamineTps
Ntp-atenolol/chlorthalidoneTeva Canada Limited
TenoreticAstra Zeneca Pharmaceuticals Lp
Tenoretic 100/25mg TabAstrazeneca Canada Inc
Tenoretic 50/25mg TabAstrazeneca Canada Inc
Teva-atenolol/chlorthalidoneTeva Canada Limited
SaltsNot Available
Categories
UNII50VV3VW0TI
CAS number29122-68-7
WeightAverage: 266.3361
Monoisotopic: 266.16304258
Chemical FormulaC14H22N2O3
InChI KeyMETKIMKYRPQLGS-UHFFFAOYSA-N
InChI
InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)
IUPAC Name
2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide
SMILES
CC(C)NCC(O)COC1=CC=C(CC(N)=O)C=C1
Taxonomy
DescriptionThis compound belongs to the class of organic compounds known as phenylacetamides. These are amide derivatives of phenylacetic acids.
KingdomOrganic compounds
Super ClassBenzenoids
ClassBenzene and substituted derivatives
Sub ClassPhenylacetamides
Direct ParentPhenylacetamides
Alternative Parents
Substituents
  • Phenylacetamide
  • Phenol ether
  • Alkyl aryl ether
  • Secondary alcohol
  • Primary carboxylic acid amide
  • Carboxamide group
  • 1,2-aminoalcohol
  • Secondary amine
  • Ether
  • Secondary aliphatic amine
  • Carboxylic acid derivative
  • Carboxylic acid amide
  • Hydrocarbon derivative
  • Organooxygen compound
  • Organonitrogen compound
  • Carbonyl group
  • Amine
  • Alcohol
  • Aromatic homomonocyclic compound
Molecular FrameworkAromatic homomonocyclic compounds
External DescriptorsNot Available
Pharmacology
IndicationFor the management of hypertention and long-term management of patients with angina pectoris
PharmacodynamicsAtenolol, a competitive beta(1)-selective adrenergic antagonist, has the lowest lipid solubility of this drug class. Although it is similar to metoprolol, atenolol differs from pindolol and propranolol in that it does not have intrinsic sympathomimetic properties or membrane-stabilizing activity. Atenolol is used alone or with chlorthalidone in the management of hypertension and edema.
Mechanism of actionLike metoprolol, atenolol competes with sympathomimetic neurotransmitters such as catecholamines for binding at beta(1)-adrenergic receptors in the heart and vascular smooth muscle, inhibiting sympathetic stimulation. This results in a reduction in resting heart rate, cardiac output, systolic and diastolic blood pressure, and reflex orthostatic hypotension. Higher doses of atenolol also competitively block beta(2)-adrenergic responses in the bronchial and vascular smooth muscles.
Related Articles
AbsorptionApproximately 50% of an oral dose is absorbed from the gastrointestinal tract, the remainder being excreted unchanged in the feces.
Volume of distributionNot Available
Protein bindingPlasma protein binding is 6-16%
Metabolism

Hepatic (minimal)

Route of eliminationApproximately 50% of an oral dose is absorbed from the gastrointestinal tract, the remainder being excreted unchanged in the feces. Unlike propranolol or metoprolol, but like nadolol, atenolol undergoes little or no metabolism by the liver, and the absorbed portion is eliminated primarily by renal excretion.
Half life6-7 hours
ClearanceNot Available
ToxicityLD50=2000-3000 mg/kg(orally in mice). Symptoms of an atenolol overdose include a slow heart beat, shortness of breath, fainting, dizziness, weakness, confusion, nausea, and vomiting.
Affected organisms
  • Humans and other mammals
Pathways
PathwayCategorySMPDB ID
Atenolol Action PathwayDrug actionSMP00298
SNP Mediated Effects
Interacting Gene/EnzymeSNP RS IDAllele nameDefining changeEffectReference(s)
Beta-1 adrenergic receptor
Gene symbol: ADRB1
UniProt: P08588
rs1801253 Not AvailableG > CBetter response to drug therapy22192668
SNP Mediated Adverse Drug ReactionsNot Available
ADMET
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+0.9831
Blood Brain Barrier-0.9505
Caco-2 permeable-0.7922
P-glycoprotein substrateSubstrate0.6773
P-glycoprotein inhibitor INon-inhibitor0.9446
P-glycoprotein inhibitor IINon-inhibitor0.9856
Renal organic cation transporterNon-inhibitor0.8959
CYP450 2C9 substrateNon-substrate0.8416
CYP450 2D6 substrateSubstrate0.5468
CYP450 3A4 substrateNon-substrate0.6826
CYP450 1A2 substrateNon-inhibitor0.9045
CYP450 2C9 inhibitorNon-inhibitor0.9163
CYP450 2D6 inhibitorNon-inhibitor0.9231
CYP450 2C19 inhibitorNon-inhibitor0.9026
CYP450 3A4 inhibitorNon-inhibitor0.9379
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.9537
Ames testNon AMES toxic0.9132
CarcinogenicityNon-carcinogens0.8691
BiodegradationNot ready biodegradable0.8969
Rat acute toxicity2.0932 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.996
hERG inhibition (predictor II)Non-inhibitor0.8861
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397 )
Pharmacoeconomics
Manufacturers
  • Astrazeneca pharmaceuticals lp
  • Able laboratories inc
  • Apothecon sub bristol myers squibb co
  • Aurobindo pharma ltd
  • Caraco pharmaceutical laboratories ltd
  • Dava pharmaceuticals inc
  • Genpharm pharmaceuticals inc
  • Ipca laboratories ltd
  • Ipr pharmaceuticals inc
  • Mutual pharmaceutical co inc
  • Mylan pharmaceuticals inc
  • Northstar healthcare holdings ltd
  • Nostrum laboratories inc
  • Pliva inc
  • Sandoz inc
  • Scs pharmaceuticals
  • Teva pharmaceuticals usa inc
  • Teva pharmaceuticals usa
  • Unique pharmaceutical laboratories
  • Watson laboratories inc
  • Zydus pharmaceuticals usa inc
  • Astrazeneca lp
Packagers
Dosage forms
FormRouteStrength
Tabletoral100 mg/1
Tabletoral25 mg/1
Tabletoral50 mg/1
Tabletoral50 mg/mg
Tabletbuccal; oral; sublingual; transmucosal
Tabletoral25 mg
Tabletoral
Tabletoral100 mg
Tabletoral50 mg
Prices
Unit descriptionCostUnit
Atenolol powder5.14USD g
Tenormin 100 mg tablet2.28USD tablet
Tenormin 25 mg tablet1.94USD tablet
Tenormin 50 mg tablet1.52USD tablet
Atenolol 100 mg tablet1.26USD tablet
Atenolol 50 mg tablet0.85USD tablet
Atenolol 25 mg tablet0.81USD tablet
Apo-Atenol 100 mg Tablet0.6USD tablet
Co Atenolol 100 mg Tablet0.6USD tablet
Mylan-Atenolol 100 mg Tablet0.6USD tablet
Novo-Atenol 100 mg Tablet0.6USD tablet
Phl-Atenolol 100 mg Tablet0.6USD tablet
Pms-Atenolol 100 mg Tablet0.6USD tablet
Ran-Atenolol 100 mg Tablet0.6USD tablet
Ratio-Atenolol 100 mg Tablet0.6USD tablet
Sandoz Atenolol 100 mg Tablet0.6USD tablet
Apo-Atenol 50 mg Tablet0.36USD tablet
Co Atenolol 50 mg Tablet0.36USD tablet
Mylan-Atenolol 50 mg Tablet0.36USD tablet
Novo-Atenol 50 mg Tablet0.36USD tablet
Phl-Atenolol 50 mg Tablet0.36USD tablet
Pms-Atenolol 50 mg Tablet0.36USD tablet
Ran-Atenolol 50 mg Tablet0.36USD tablet
Ratio-Atenolol 50 mg Tablet0.36USD tablet
Sandoz Atenolol 50 mg Tablet0.36USD tablet
Novo-Atenol 25 mg Tablet0.18USD tablet
Pms-Atenolol 25 mg Tablet0.18USD tablet
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
PatentsNot Available
Properties
StateSolid
Experimental Properties
PropertyValueSource
melting point158-160Barrett, A.M., Carter, J., Hull, R., Le Count, D.J. and Squire, C.J.; U.S. Patent 3,663,607; May 16, 1972; assigned to Imperial Chemical Industries Limited, England. Barrett, A.M., Carter, J., Hull, R., Le Count, D.J. and Squire, C.J.; U.S. Patent 3,836,671; September 17, 1974; assigned to Imperial Chemical Industries Limited, England.
water solubility1.33E+004 mg/L (at 25 °C)MCFARLAND,JW ET AL. (2001)
logP0.16HANSCH,C ET AL. (1995)
Caco2 permeability-6.44ADME Research, USCD
pKa9.6MERCK INDEX (2001)
Predicted Properties
PropertyValueSource
Water Solubility0.429 mg/mLALOGPS
logP0.57ALOGPS
logP0.43ChemAxon
logS-2.8ALOGPS
pKa (Strongest Acidic)14.08ChemAxon
pKa (Strongest Basic)9.67ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count4ChemAxon
Hydrogen Donor Count3ChemAxon
Polar Surface Area84.58 Å2ChemAxon
Rotatable Bond Count8ChemAxon
Refractivity73.51 m3·mol-1ChemAxon
Polarizability29.98 Å3ChemAxon
Number of Rings1ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleYesChemAxon
Spectra
Mass Spec (NIST)Not Available
Spectra
Spectrum TypeDescriptionSplash Key
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 10V, Positive (Annotated)splash10-0uy0-0950000000-e882b8032954e2a624cfView in MoNA
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 25V, Positive (Annotated)splash10-0076-4920000000-3c7f23b7695e5c4dcc4cView in MoNA
LC-MS/MSLC-MS/MS Spectrum - Quattro_QQQ 40V, Positive (Annotated)splash10-0aos-9800000000-93a18f0e030605aa10aaView in MoNA
MSMass Spectrum (Electron Ionization)splash10-00e9-9000000000-6a38697da7945fdb1908View in MoNA
1D NMR1H NMR SpectrumNot Available
1D NMR1H NMR SpectrumNot Available
1D NMR13C NMR SpectrumNot Available
2D NMR[1H,13C] 2D NMR SpectrumNot Available
References
Synthesis Reference

Barrett, A.M., Carter, J., Hull, R., Le Count, D.J. and Squire, C.J.; U.S. Patent 3,663,607;
May 16, 1972; assigned to Imperial Chemical Industries Limited, England.
Barrett, A.M., Carter, J., Hull, R., Le Count, D.J. and Squire, C.J.; U.S. Patent 3,836,671;
September 17, 1974; assigned to Imperial Chemical Industries Limited, England.

US3663607
General ReferencesNot Available
External Links
ATC CodesC07CB03C07DB01C07FB03C07AB03C07BB03C07CB53
AHFS Codes
  • 24:24.00
PDB EntriesNot Available
FDA labelDownload (112 KB)
MSDSDownload (72.9 KB)
Interactions
Drug Interactions
Drug
1,10-Phenanthroline1,10-Phenanthroline may increase the bradycardic activities of Atenolol.
4-Methoxyamphetamine4-Methoxyamphetamine may increase the atrioventricular blocking (AV block) activities of Atenolol.
7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE7,8-DICHLORO-1,2,3,4-TETRAHYDROISOQUINOLINE may increase the hypotensive activities of Atenolol.
AcebutololAtenolol may increase the hypotensive activities of Acebutolol.
AceclofenacAceclofenac may decrease the antihypertensive activities of Atenolol.
AcepromazineAcepromazine may increase the hypotensive activities of Atenolol.
AcetaminophenThe serum concentration of Atenolol can be increased when it is combined with Acetaminophen.
AcetazolamideThe risk or severity of adverse effects can be increased when Atenolol is combined with Acetazolamide.
AcetohexamideAtenolol may increase the hypoglycemic activities of Acetohexamide.
AcetylcholineThe risk or severity of adverse effects can be increased when Atenolol is combined with Acetylcholine.
AcetyldigitoxinAtenolol may increase the bradycardic activities of Acetyldigitoxin.
Acetylsalicylic acidAcetylsalicylic acid may decrease the antihypertensive activities of Atenolol.
Acetylsalicylic acidThe serum concentration of Acetylsalicylic acid can be increased when it is combined with Atenolol.
AdapaleneAdapalene may decrease the antihypertensive activities of Atenolol.
AfatinibThe serum concentration of Afatinib can be increased when it is combined with Atenolol.
AgmatineAgmatine may increase the atrioventricular blocking (AV block) activities of Atenolol.
AlbendazoleThe serum concentration of Atenolol can be increased when it is combined with Albendazole.
AldesleukinThe risk or severity of adverse effects can be increased when Aldesleukin is combined with Atenolol.
AldosteroneThe serum concentration of Atenolol can be decreased when it is combined with Aldosterone.
AldosteroneThe serum concentration of Aldosterone can be increased when it is combined with Atenolol.
AlectinibThe serum concentration of Atenolol can be increased when it is combined with Alectinib.
AlfentanilThe serum concentration of Atenolol can be increased when it is combined with Alfentanil.
AlfuzosinAlfuzosin may increase the hypotensive activities of Atenolol.
AlfuzosinAtenolol may increase the orthostatic hypotensive activities of Alfuzosin.
AlimemazineAlimemazine may increase the hypotensive activities of Atenolol.
AliskirenAtenolol may increase the hypotensive activities of Aliskiren.
AlitretinoinThe serum concentration of Alitretinoin can be increased when it is combined with Atenolol.
AlprenololAtenolol may increase the hypotensive activities of Alprenolol.
AmantadineThe serum concentration of Atenolol can be increased when it is combined with Amantadine.
AmbenoniumAmbenonium may increase the bradycardic activities of Atenolol.
AmbrisentanAtenolol may increase the hypotensive activities of Ambrisentan.
AmifostineAtenolol may increase the hypotensive activities of Amifostine.
AmilorideThe risk or severity of adverse effects can be increased when Atenolol is combined with Amiloride.
Aminohippuric acidThe serum concentration of Atenolol can be increased when it is combined with Aminohippuric acid.
AminophyllineAtenolol may decrease the bronchodilatory activities of Aminophylline.
AmiodaroneAmiodarone may increase the bradycardic activities of Atenolol.
AmitriptylineThe serum concentration of Amitriptyline can be increased when it is combined with Atenolol.
AmlodipineAtenolol may increase the hypotensive activities of Amlodipine.
AmobarbitalAmobarbital may increase the hypotensive activities of Atenolol.
AmodiaquineThe metabolism of Atenolol can be decreased when combined with Amodiaquine.
AmoxapineThe serum concentration of Atenolol can be increased when it is combined with Amoxapine.
AmpicillinThe bioavailability of Atenolol can be decreased when combined with Ampicillin.
AmprenavirThe serum concentration of Atenolol can be decreased when it is combined with Amprenavir.
AmsacrineThe serum concentration of Atenolol can be increased when it is combined with Amsacrine.
Amyl NitriteThe risk or severity of adverse effects can be increased when Atenolol is combined with Amyl Nitrite.
AntipyrineAntipyrine may decrease the antihypertensive activities of Atenolol.
ApixabanThe serum concentration of Apixaban can be increased when it is combined with Atenolol.
ApomorphineApomorphine may increase the atrioventricular blocking (AV block) activities of Atenolol.
ApraclonidineThe risk or severity of adverse effects can be increased when Atenolol is combined with Apraclonidine.
ApremilastApremilast may decrease the antihypertensive activities of Atenolol.
ArbutamineAtenolol may decrease the bronchodilatory activities of Arbutamine.
ArecolineThe risk or severity of adverse effects can be increased when Atenolol is combined with Arecoline.
ArformoterolAtenolol may decrease the bronchodilatory activities of Arformoterol.
AripiprazoleAripiprazole may increase the hypotensive activities of Atenolol.
Arsenic trioxideThe serum concentration of Arsenic trioxide can be increased when it is combined with Atenolol.
AstemizoleThe serum concentration of Atenolol can be increased when it is combined with Astemizole.
AtazanavirThe serum concentration of Atazanavir can be increased when it is combined with Atenolol.
AtorvastatinThe serum concentration of Atenolol can be increased when it is combined with Atorvastatin.
AxitinibThe serum concentration of Axitinib can be increased when it is combined with Atenolol.
AzapropazoneAzapropazone may decrease the antihypertensive activities of Atenolol.
AzelastineAzelastine may decrease the antihypertensive activities of Atenolol.
Azilsartan medoxomilThe risk or severity of adverse effects can be increased when Atenolol is combined with Azilsartan medoxomil.
AzithromycinThe serum concentration of Atenolol can be increased when it is combined with Azithromycin.
BalsalazideBalsalazide may decrease the antihypertensive activities of Atenolol.
BambuterolAtenolol may decrease the bronchodilatory activities of Bambuterol.
BarbitalBarbital may increase the hypotensive activities of Atenolol.
BenazeprilAtenolol may increase the hypotensive activities of Benazepril.
BendroflumethiazideAtenolol may increase the hypotensive activities of Bendroflumethiazide.
BenmoxinBenmoxin may increase the hypotensive activities of Atenolol.
BenoxaprofenBenoxaprofen may decrease the antihypertensive activities of Atenolol.
BenzocaineThe serum concentration of Atenolol can be increased when it is combined with Benzocaine.
BenzphetamineBenzphetamine may increase the atrioventricular blocking (AV block) activities of Atenolol.
BepridilAtenolol may increase the hypotensive activities of Bepridil.
BeractantAtenolol may increase the bradycardic activities of Beractant.
BetamethasoneThe serum concentration of Betamethasone can be increased when it is combined with Atenolol.
BetaxololBetaxolol may increase the hypotensive activities of Atenolol.
BethanecholThe risk or severity of adverse effects can be increased when Atenolol is combined with Bethanechol.
BethanidineBethanidine may increase the hypotensive activities of Atenolol.
BimatoprostAtenolol may increase the hypotensive activities of Bimatoprost.
BiperidenThe serum concentration of Atenolol can be increased when it is combined with Biperiden.
BisoprololAtenolol may increase the hypotensive activities of Bisoprolol.
BoceprevirThe serum concentration of Boceprevir can be increased when it is combined with Atenolol.
BosentanAtenolol may increase the hypotensive activities of Bosentan.
BosutinibThe serum concentration of Bosutinib can be increased when it is combined with Atenolol.
Brentuximab vedotinThe serum concentration of Brentuximab vedotin can be increased when it is combined with Atenolol.
BretyliumBretylium may increase the bradycardic activities of Atenolol.
BretyliumAtenolol may increase the hypotensive activities of Bretylium.
BrimonidineAtenolol may increase the hypotensive activities of Brimonidine.
BrimonidineBrimonidine may increase the antihypertensive activities of Atenolol.
BromfenacBromfenac may decrease the antihypertensive activities of Atenolol.
BromocriptineThe serum concentration of Bromocriptine can be increased when it is combined with Atenolol.
BumetanideThe risk or severity of adverse effects can be increased when Atenolol is combined with Bumetanide.
BupivacaineThe serum concentration of Bupivacaine can be increased when it is combined with Atenolol.
BupranololAtenolol may increase the hypotensive activities of Bupranolol.
BuprenorphineThe serum concentration of Atenolol can be increased when it is combined with Buprenorphine.
BuspironeThe serum concentration of Atenolol can be increased when it is combined with Buspirone.
CabazitaxelThe serum concentration of Cabazitaxel can be increased when it is combined with Atenolol.
CabergolineAtenolol may increase the vasoconstricting activities of Cabergoline.
CaffeineThe serum concentration of Caffeine can be increased when it is combined with Atenolol.
CalfactantAtenolol may increase the bradycardic activities of Calfactant.
CamptothecinThe serum concentration of Camptothecin can be increased when it is combined with Atenolol.
CanagliflozinThe risk or severity of adverse effects can be increased when Atenolol is combined with Canagliflozin.
CandesartanAtenolol may increase the hypotensive activities of Candesartan.
CandoxatrilAtenolol may increase the hypotensive activities of Candoxatril.
CaptoprilAtenolol may increase the hypotensive activities of Captopril.
CarbacholThe risk or severity of adverse effects can be increased when Atenolol is combined with Carbachol.
CarbamazepineThe serum concentration of Atenolol can be decreased when it is combined with Carbamazepine.
CarbamazepineThe serum concentration of Carbamazepine can be increased when it is combined with Atenolol.
CarfilzomibThe serum concentration of Carfilzomib can be increased when it is combined with Atenolol.
CaroxazoneCaroxazone may increase the hypotensive activities of Atenolol.
CarprofenCarprofen may decrease the antihypertensive activities of Atenolol.
CarteololAtenolol may increase the hypotensive activities of Carteolol.
CarvedilolAtenolol may increase the hypotensive activities of Carvedilol.
CaspofunginThe serum concentration of Atenolol can be increased when it is combined with Caspofungin.
CastanospermineCastanospermine may decrease the antihypertensive activities of Atenolol.
CelecoxibCelecoxib may decrease the antihypertensive activities of Atenolol.
CeliprololAtenolol may increase the hypotensive activities of Celiprolol.
CeritinibAtenolol may increase the bradycardic activities of Ceritinib.
CerivastatinThe serum concentration of Cerivastatin can be increased when it is combined with Atenolol.
CevimelineThe risk or severity of adverse effects can be increased when Atenolol is combined with Cevimeline.
ChloroquineChloroquine may decrease the antihypertensive activities of Atenolol.
ChlorothiazideAtenolol may increase the hypotensive activities of Chlorothiazide.
ChlorpromazineChlorpromazine may increase the hypotensive activities of Atenolol.
ChlorpromazineThe serum concentration of Chlorpromazine can be increased when it is combined with Atenolol.
ChlorpropamideAtenolol may increase the hypoglycemic activities of Chlorpropamide.
ChlorpropamideThe serum concentration of Atenolol can be increased when it is combined with Chlorpropamide.
ChlorprothixeneThe serum concentration of Atenolol can be increased when it is combined with Chlorprothixene.
ChlorthalidoneChlorthalidone may increase the hypotensive activities of Atenolol.
CholesterolThe serum concentration of Atenolol can be increased when it is combined with Cholesterol.
Cholic AcidThe serum concentration of Atenolol can be decreased when it is combined with Cholic Acid.
CilazaprilAtenolol may increase the hypotensive activities of Cilazapril.
CimetidineThe serum concentration of Atenolol can be decreased when it is combined with Cimetidine.
CimetidineThe serum concentration of Cimetidine can be increased when it is combined with Atenolol.
CiprofloxacinThe serum concentration of Atenolol can be increased when it is combined with Ciprofloxacin.
CisplatinThe serum concentration of Cisplatin can be increased when it is combined with Atenolol.
CitalopramThe serum concentration of Citalopram can be increased when it is combined with Atenolol.
ClarithromycinThe serum concentration of Atenolol can be increased when it is combined with Clarithromycin.
ClenbuterolAtenolol may decrease the bronchodilatory activities of Clenbuterol.
ClevidipineThe risk or severity of adverse effects can be increased when Atenolol is combined with Clevidipine.
ClobazamThe serum concentration of Clobazam can be increased when it is combined with Atenolol.
ClofazimineThe serum concentration of Atenolol can be increased when it is combined with Clofazimine.
ClomifeneThe serum concentration of Clomifene can be increased when it is combined with Atenolol.
ClomipramineThe serum concentration of Atenolol can be increased when it is combined with Clomipramine.
ClonidineAtenolol may increase the hypotensive activities of Clonidine.
ClonixinClonixin may decrease the antihypertensive activities of Atenolol.
ClopidogrelThe serum concentration of Clopidogrel can be increased when it is combined with Atenolol.
ClotrimazoleThe serum concentration of Atenolol can be decreased when it is combined with Clotrimazole.
ClozapineThe serum concentration of Clozapine can be increased when it is combined with Atenolol.
CobicistatThe serum concentration of Atenolol can be increased when it is combined with Cobicistat.
CobimetinibThe serum concentration of Cobimetinib can be increased when it is combined with Atenolol.
ColchicineThe serum concentration of Atenolol can be increased when it is combined with Colchicine.
ColforsinThe serum concentration of Atenolol can be increased when it is combined with Colforsin.
Conjugated Equine EstrogensThe serum concentration of Conjugated Equine Estrogens can be increased when it is combined with Atenolol.
CoumaphosCoumaphos may increase the bradycardic activities of Atenolol.
CrizotinibThe serum concentration of Crizotinib can be increased when it is combined with Atenolol.
CryptenamineAtenolol may increase the hypotensive activities of Cryptenamine.
CyclophosphamideThe serum concentration of Atenolol can be increased when it is combined with Cyclophosphamide.
CyclosporineThe serum concentration of Atenolol can be decreased when it is combined with Cyclosporine.
CyclosporineThe serum concentration of Cyclosporine can be increased when it is combined with Atenolol.
CyclothiazideAtenolol may increase the hypotensive activities of Cyclothiazide.
D-LimoneneD-Limonene may decrease the antihypertensive activities of Atenolol.
Dabigatran etexilateThe serum concentration of Dabigatran etexilate can be increased when it is combined with Atenolol.
DabrafenibThe serum concentration of Dabrafenib can be increased when it is combined with Atenolol.
DaclatasvirThe serum concentration of Atenolol can be increased when it is combined with Daclatasvir.
DactinomycinThe serum concentration of Atenolol can be increased when it is combined with Dactinomycin.
DapagliflozinThe risk or severity of adverse effects can be increased when Atenolol is combined with Dapagliflozin.
DapoxetineThe serum concentration of Atenolol can be increased when it is combined with Dapoxetine.
DasatinibThe serum concentration of Dasatinib can be increased when it is combined with Atenolol.
DaunorubicinThe serum concentration of Atenolol can be decreased when it is combined with Daunorubicin.
DaunorubicinThe serum concentration of Daunorubicin can be increased when it is combined with Atenolol.
DebrisoquinAtenolol may increase the hypotensive activities of Debrisoquin.
DecamethoniumDecamethonium may increase the bradycardic activities of Atenolol.
DemecariumDemecarium may increase the bradycardic activities of Atenolol.
DeserpidineAtenolol may increase the hypotensive activities of Deserpidine.
DesipramineThe serum concentration of Atenolol can be increased when it is combined with Desipramine.
DeslanosideAtenolol may increase the bradycardic activities of Deslanoside.
DesloratadineThe serum concentration of Atenolol can be increased when it is combined with Desloratadine.
DexamethasoneThe serum concentration of Atenolol can be decreased when it is combined with Dexamethasone.
DexamethasoneThe serum concentration of Dexamethasone can be increased when it is combined with Atenolol.
DexmedetomidineThe risk or severity of adverse effects can be increased when Atenolol is combined with Dexmedetomidine.
DextromethorphanThe serum concentration of Atenolol can be increased when it is combined with Dextromethorphan.
DiazepamThe serum concentration of Diazepam can be increased when it is combined with Atenolol.
DiazoxideDiazoxide may increase the hypotensive activities of Atenolol.
DichlorvosDichlorvos may increase the bradycardic activities of Atenolol.
DiclofenacDiclofenac may decrease the antihypertensive activities of Atenolol.
DiclofenamideThe risk or severity of adverse effects can be increased when Atenolol is combined with Diclofenamide.
DiethylstilbestrolThe serum concentration of Diethylstilbestrol can be increased when it is combined with Atenolol.
DiflunisalDiflunisal may decrease the antihypertensive activities of Atenolol.
DigitoxinAtenolol may increase the bradycardic activities of Digitoxin.
DigoxinAtenolol may increase the bradycardic activities of Digoxin.
DigoxinThe serum concentration of Atenolol can be decreased when it is combined with Digoxin.
DihydroergotamineAtenolol may increase the vasoconstricting activities of Dihydroergotamine.
DihydroergotamineThe serum concentration of Atenolol can be increased when it is combined with Dihydroergotamine.
DihydrotestosteroneThe serum concentration of Dihydrotestosterone can be increased when it is combined with Atenolol.
DiltiazemAtenolol may increase the hypotensive activities of Diltiazem.
DinutuximabThe risk or severity of adverse effects can be increased when Atenolol is combined with Dinutuximab.
DipivefrinDipivefrin may increase the atrioventricular blocking (AV block) activities of Atenolol.
DipivefrinAtenolol may decrease the bronchodilatory activities of Dipivefrin.
DipyridamoleDipyridamole may increase the bradycardic activities of Atenolol.
DipyridamoleThe risk or severity of adverse effects can be increased when Atenolol is combined with Dipyridamole.
DisopyramideDisopyramide may increase the bradycardic activities of Atenolol.
DobutamineAtenolol may decrease the bronchodilatory activities of Dobutamine.
DocetaxelThe serum concentration of Docetaxel can be increased when it is combined with Atenolol.
DomperidoneThe serum concentration of Domperidone can be increased when it is combined with Atenolol.
DonepezilDonepezil may increase the bradycardic activities of Atenolol.
DorzolamideAtenolol may increase the hypotensive activities of Dorzolamide.
DoxazosinAtenolol may increase the hypotensive activities of Doxazosin.
DoxepinThe serum concentration of Atenolol can be increased when it is combined with Doxepin.
DoxorubicinThe serum concentration of Atenolol can be decreased when it is combined with Doxorubicin.
DoxorubicinThe serum concentration of Doxorubicin can be increased when it is combined with Atenolol.
DronabinolThe serum concentration of Atenolol can be increased when it is combined with Dronabinol.
DronedaroneThe serum concentration of Atenolol can be increased when it is combined with Dronedarone.
DronedaroneAtenolol may increase the bradycardic activities of Dronedarone.
DroxicamDroxicam may decrease the antihypertensive activities of Atenolol.
DroxidopaDroxidopa may increase the atrioventricular blocking (AV block) activities of Atenolol.
DroxidopaAtenolol may decrease the bronchodilatory activities of Droxidopa.
DuloxetineAtenolol may increase the orthostatic hypotensive activities of Duloxetine.
DyphyllineAtenolol may decrease the bronchodilatory activities of Dyphylline.
EchothiophateEchothiophate may increase the bradycardic activities of Atenolol.
EdoxabanThe serum concentration of Edoxaban can be increased when it is combined with Atenolol.
EdrophoniumEdrophonium may increase the bradycardic activities of Atenolol.
EfonidipineAtenolol may increase the hypotensive activities of Efonidipine.
ElbasvirThe serum concentration of Atenolol can be increased when it is combined with Elbasvir.
EletriptanThe serum concentration of Eletriptan can be increased when it is combined with Atenolol.
EmpagliflozinThe risk or severity of adverse effects can be increased when Atenolol is combined with Empagliflozin.
EnalaprilAtenolol may increase the hypotensive activities of Enalapril.
EnalaprilatAtenolol may increase the hypotensive activities of Enalaprilat.
EnzalutamideThe serum concentration of Atenolol can be increased when it is combined with Enzalutamide.
EphedraEphedra may increase the atrioventricular blocking (AV block) activities of Atenolol.
EphedraAtenolol may decrease the bronchodilatory activities of Ephedra.
EPIBATIDINEThe risk or severity of adverse effects can be increased when Atenolol is combined with EPIBATIDINE.
EpinastineThe serum concentration of Epinastine can be increased when it is combined with Atenolol.
EpinephrineEpinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.
EpinephrineAtenolol may decrease the bronchodilatory activities of Epinephrine.
EpirizoleEpirizole may decrease the antihypertensive activities of Atenolol.
EplerenoneThe risk or severity of adverse effects can be increased when Atenolol is combined with Eplerenone.
EpoprostenolAtenolol may increase the hypotensive activities of Epoprostenol.
EprosartanAtenolol may increase the hypotensive activities of Eprosartan.
Ergoloid mesylateAtenolol may increase the vasoconstricting activities of Ergoloid mesylate.
ErgonovineAtenolol may increase the vasoconstricting activities of Ergonovine.
ErgonovineThe serum concentration of Atenolol can be increased when it is combined with Ergonovine.
ErgotamineAtenolol may increase the vasoconstricting activities of Ergotamine.
ErgotamineThe serum concentration of Atenolol can be increased when it is combined with Ergotamine.
ErlotinibThe serum concentration of Erlotinib can be increased when it is combined with Atenolol.
ErythromycinThe serum concentration of Atenolol can be decreased when it is combined with Erythromycin.
ErythromycinThe serum concentration of Erythromycin can be increased when it is combined with Atenolol.
EsmololThe risk or severity of adverse effects can be increased when Esmolol is combined with Atenolol.
EstradiolThe serum concentration of Estradiol can be increased when it is combined with Atenolol.
EstramustineThe serum concentration of Atenolol can be increased when it is combined with Estramustine.
EstriolThe serum concentration of Atenolol can be decreased when it is combined with Estriol.
EstriolThe serum concentration of Estriol can be increased when it is combined with Atenolol.
EstroneThe serum concentration of Atenolol can be decreased when it is combined with Estrone.
EstroneThe serum concentration of Estrone can be increased when it is combined with Atenolol.
Etacrynic acidThe risk or severity of adverse effects can be increased when Atenolol is combined with Etacrynic acid.
EtanerceptEtanercept may decrease the antihypertensive activities of Atenolol.
Ethinyl EstradiolThe serum concentration of Ethinyl Estradiol can be increased when it is combined with Atenolol.
EtodolacEtodolac may decrease the antihypertensive activities of Atenolol.
EtofenamateEtofenamate may decrease the antihypertensive activities of Atenolol.
EtomidateEtomidate may increase the atrioventricular blocking (AV block) activities of Atenolol.
EtoperidoneThe serum concentration of Atenolol can be increased when it is combined with Etoperidone.
EtoposideThe serum concentration of Atenolol can be increased when it is combined with Etoposide.
EtoricoxibEtoricoxib may decrease the antihypertensive activities of Atenolol.
EtravirineThe serum concentration of Atenolol can be increased when it is combined with Etravirine.
Evening primrose oilEvening primrose oil may decrease the antihypertensive activities of Atenolol.
EverolimusThe serum concentration of Everolimus can be increased when it is combined with Atenolol.
exisulindexisulind may decrease the antihypertensive activities of Atenolol.
EzetimibeThe serum concentration of Ezetimibe can be increased when it is combined with Atenolol.
FelodipineAtenolol may increase the hypotensive activities of Felodipine.
FenbufenFenbufen may decrease the antihypertensive activities of Atenolol.
FenfluramineThe serum concentration of Atenolol can be increased when it is combined with Fenfluramine.
FenoldopamAtenolol may increase the hypotensive activities of Fenoldopam.
FenoprofenFenoprofen may decrease the antihypertensive activities of Atenolol.
FenoterolAtenolol may decrease the bronchodilatory activities of Fenoterol.
FentanylThe serum concentration of Atenolol can be increased when it is combined with Fentanyl.
FenthionFenthion may increase the bradycardic activities of Atenolol.
FesoterodineThe serum concentration of Fesoterodine can be increased when it is combined with Atenolol.
FexofenadineThe serum concentration of Fexofenadine can be increased when it is combined with Atenolol.
FidaxomicinThe serum concentration of Fidaxomicin can be increased when it is combined with Atenolol.
FingolimodAtenolol may increase the bradycardic activities of Fingolimod.
FloctafenineThe risk or severity of adverse effects can be increased when Floctafenine is combined with Atenolol.
FluconazoleThe serum concentration of Atenolol can be increased when it is combined with Fluconazole.
FlunixinFlunixin may decrease the antihypertensive activities of Atenolol.
FluoxetineThe serum concentration of Atenolol can be increased when it is combined with Fluoxetine.
FlupentixolThe serum concentration of Atenolol can be increased when it is combined with Flupentixol.
FluphenazineFluphenazine may increase the hypotensive activities of Atenolol.
FlurazepamThe serum concentration of Atenolol can be increased when it is combined with Flurazepam.
FlurbiprofenFlurbiprofen may decrease the antihypertensive activities of Atenolol.
Fluticasone furoateThe serum concentration of Fluticasone furoate can be increased when it is combined with Atenolol.
FluvoxamineThe serum concentration of Atenolol can be increased when it is combined with Fluvoxamine.
FormoterolAtenolol may decrease the bronchodilatory activities of Formoterol.
FosinoprilAtenolol may increase the hypotensive activities of Fosinopril.
FurazolidoneFurazolidone may increase the hypotensive activities of Atenolol.
FurosemideThe risk or severity of adverse effects can be increased when Atenolol is combined with Furosemide.
GalantamineGalantamine may increase the bradycardic activities of Atenolol.
Gallamine TriethiodideGallamine Triethiodide may increase the bradycardic activities of Atenolol.
GefitinibThe serum concentration of Gefitinib can be increased when it is combined with Atenolol.
GemcitabineThe serum concentration of Gemcitabine can be increased when it is combined with Atenolol.
GenisteinThe serum concentration of Atenolol can be increased when it is combined with Genistein.
Ginkgo bilobaGinkgo biloba may increase the bradycardic activities of Atenolol.
GlibornurideAtenolol may increase the hypoglycemic activities of Glibornuride.
GliclazideAtenolol may increase the hypoglycemic activities of Gliclazide.
GlimepirideAtenolol may increase the hypoglycemic activities of Glimepiride.
GlipizideAtenolol may increase the hypoglycemic activities of Glipizide.
GliquidoneAtenolol may increase the hypoglycemic activities of Gliquidone.
GlisoxepideAtenolol may increase the hypoglycemic activities of Glisoxepide.
GlyburideAtenolol may increase the hypoglycemic activities of Glyburide.
GlyburideThe serum concentration of Atenolol can be increased when it is combined with Glyburide.
GlycerolThe serum concentration of Atenolol can be increased when it is combined with Glycerol.
GlycopyrroniumThe serum concentration of Atenolol can be increased when it is combined with Glycopyrronium.
Gramicidin DThe serum concentration of Atenolol can be increased when it is combined with Gramicidin D.
GrazoprevirThe serum concentration of Grazoprevir can be increased when it is combined with Atenolol.
GrepafloxacinThe serum concentration of Grepafloxacin can be increased when it is combined with Atenolol.
GTS-21The risk or severity of adverse effects can be increased when Atenolol is combined with GTS-21.
GuanabenzAtenolol may increase the hypotensive activities of Guanabenz.
GuanadrelGuanadrel may increase the hypotensive activities of Atenolol.
GuanethidineAtenolol may increase the hypotensive activities of Guanethidine.
GuanfacineAtenolol may increase the hypotensive activities of Guanfacine.
HaloperidolThe serum concentration of Haloperidol can be increased when it is combined with Atenolol.
HexamethoniumAtenolol may increase the hypotensive activities of Hexamethonium.
HexobarbitalHexobarbital may increase the hypotensive activities of Atenolol.
HMPL-004HMPL-004 may decrease the antihypertensive activities of Atenolol.
Huperzine AHuperzine A may increase the bradycardic activities of Atenolol.
HydracarbazineHydracarbazine may increase the hypotensive activities of Atenolol.
HydralazineAtenolol may increase the hypotensive activities of Hydralazine.
HydrochlorothiazideAtenolol may increase the hypotensive activities of Hydrochlorothiazide.
HydrocortisoneThe serum concentration of Hydrocortisone can be increased when it is combined with Atenolol.
HydroflumethiazideAtenolol may increase the hypotensive activities of Hydroflumethiazide.
HydroxychloroquineThe metabolism of Atenolol can be decreased when combined with Hydroxychloroquine.
IbuprofenIbuprofen may decrease the antihypertensive activities of Atenolol.
IbuprofenThe serum concentration of Ibuprofen can be increased when it is combined with Atenolol.
IbuproxamIbuproxam may decrease the antihypertensive activities of Atenolol.
IcatibantIcatibant may decrease the antihypertensive activities of Atenolol.
IdelalisibThe serum concentration of Idelalisib can be increased when it is combined with Atenolol.
IloprostIloprost may increase the hypotensive activities of Atenolol.
ImatinibThe serum concentration of Imatinib can be increased when it is combined with Atenolol.
ImipramineThe serum concentration of Imipramine can be increased when it is combined with Atenolol.
IndacaterolThe serum concentration of Indacaterol can be increased when it is combined with Atenolol.
IndalpineThe serum concentration of Atenolol can be increased when it is combined with Indalpine.
IndapamideAtenolol may increase the hypotensive activities of Indapamide.
IndenololAtenolol may increase the hypotensive activities of Indenolol.
IndinavirThe serum concentration of Atenolol can be decreased when it is combined with Indinavir.
IndinavirThe serum concentration of Indinavir can be increased when it is combined with Atenolol.
IndomethacinIndomethacin may decrease the antihypertensive activities of Atenolol.
IndomethacinThe serum concentration of Indomethacin can be increased when it is combined with Atenolol.
IndoprofenIndoprofen may decrease the antihypertensive activities of Atenolol.
IndoraminAtenolol may increase the hypotensive activities of Indoramin.
Insulin PorkAtenolol may increase the hypoglycemic activities of Insulin Pork.
IproclozideIproclozide may increase the hypotensive activities of Atenolol.
IproniazidIproniazid may increase the hypotensive activities of Atenolol.
IrbesartanAtenolol may increase the hypotensive activities of Irbesartan.
IrinotecanThe serum concentration of Irinotecan can be increased when it is combined with Atenolol.
IsavuconazoniumThe serum concentration of Atenolol can be increased when it is combined with Isavuconazonium.
IsocarboxazidIsocarboxazid may increase the hypotensive activities of Atenolol.
IsoetarineAtenolol may decrease the bronchodilatory activities of Isoetarine.
IsoflurophateIsoflurophate may increase the bradycardic activities of Atenolol.
IsoprenalineAtenolol may decrease the bronchodilatory activities of Isoprenaline.
Isosorbide DinitrateThe risk or severity of adverse effects can be increased when Atenolol is combined with Isosorbide Dinitrate.
Isosorbide MononitrateThe risk or severity of adverse effects can be increased when Atenolol is combined with Isosorbide Mononitrate.
IsoxicamIsoxicam may decrease the antihypertensive activities of Atenolol.
IsoxsuprineThe risk or severity of adverse effects can be increased when Atenolol is combined with Isoxsuprine.
IsradipineIsradipine may increase the hypotensive activities of Atenolol.
ItraconazoleThe serum concentration of Atenolol can be increased when it is combined with Itraconazole.
IvabradineAtenolol may increase the bradycardic activities of Ivabradine.
IvacaftorThe serum concentration of Atenolol can be increased when it is combined with Ivacaftor.
IvermectinThe serum concentration of Ivermectin can be increased when it is combined with Atenolol.
KebuzoneKebuzone may decrease the antihypertensive activities of Atenolol.
KetamineThe serum concentration of Atenolol can be increased when it is combined with Ketamine.
KetazolamThe serum concentration of Ketazolam can be increased when it is combined with Atenolol.
KetoconazoleThe serum concentration of Atenolol can be increased when it is combined with Ketoconazole.
KetoprofenKetoprofen may decrease the antihypertensive activities of Atenolol.
KetorolacKetorolac may decrease the antihypertensive activities of Atenolol.
LabetalolAtenolol may increase the hypotensive activities of Labetalol.
LacidipineAtenolol may increase the hypotensive activities of Lacidipine.
LacosamideAtenolol may increase the atrioventricular blocking (AV block) activities of Lacosamide.
LamivudineThe serum concentration of Lamivudine can be increased when it is combined with Atenolol.
LamotrigineThe serum concentration of Lamotrigine can be increased when it is combined with Atenolol.
LanreotideAtenolol may increase the bradycardic activities of Lanreotide.
LansoprazoleThe serum concentration of Atenolol can be increased when it is combined with Lansoprazole.
LapatinibThe serum concentration of Atenolol can be increased when it is combined with Lapatinib.
LatanoprostAtenolol may increase the hypotensive activities of Latanoprost.
LedipasvirThe serum concentration of Ledipasvir can be increased when it is combined with Atenolol.
LeflunomideLeflunomide may decrease the antihypertensive activities of Atenolol.
LenalidomideThe serum concentration of Lenalidomide can be increased when it is combined with Atenolol.
LenvatinibThe serum concentration of Lenvatinib can be increased when it is combined with Atenolol.
LercanidipineAtenolol may increase the hypotensive activities of Lercanidipine.
LevetiracetamThe serum concentration of Levetiracetam can be increased when it is combined with Atenolol.
LevobunololThe risk or severity of adverse effects can be increased when Atenolol is combined with Levobunolol.
LevodopaAtenolol may increase the orthostatic hypotensive activities of Levodopa.
LevofloxacinThe serum concentration of Levofloxacin can be increased when it is combined with Atenolol.
LevomilnacipranThe serum concentration of Atenolol can be increased when it is combined with Levomilnacipran.
LevothyroxineThe serum concentration of Atenolol can be decreased when it is combined with Levothyroxine.
LidocaineThe serum concentration of Lidocaine can be increased when it is combined with Atenolol.
LinagliptinThe serum concentration of Linagliptin can be increased when it is combined with Atenolol.
LiothyronineThe serum concentration of Atenolol can be decreased when it is combined with Liothyronine.
LiotrixThe serum concentration of Atenolol can be decreased when it is combined with Liotrix.
LisinoprilAtenolol may increase the hypotensive activities of Lisinopril.
LobelineThe risk or severity of adverse effects can be increased when Atenolol is combined with Lobeline.
LofexidineAtenolol may increase the hypotensive activities of Lofexidine.
LomitapideThe serum concentration of Atenolol can be increased when it is combined with Lomitapide.
LoperamideThe serum concentration of Loperamide can be increased when it is combined with Atenolol.
LopinavirThe serum concentration of Atenolol can be increased when it is combined with Lopinavir.
LoratadineThe serum concentration of Atenolol can be increased when it is combined with Loratadine.
LornoxicamLornoxicam may decrease the antihypertensive activities of Atenolol.
LosartanAtenolol may increase the hypotensive activities of Losartan.
LovastatinThe serum concentration of Atenolol can be increased when it is combined with Lovastatin.
LoxoprofenLoxoprofen may decrease the antihypertensive activities of Atenolol.
Lu AA21004The serum concentration of Atenolol can be increased when it is combined with Lu AA21004.
LucinactantAtenolol may increase the bradycardic activities of Lucinactant.
LumacaftorThe serum concentration of Atenolol can be decreased when it is combined with Lumacaftor.
LumiracoxibLumiracoxib may decrease the antihypertensive activities of Atenolol.
MacitentanAtenolol may increase the hypotensive activities of Macitentan.
Magnesium salicylateMagnesium salicylate may decrease the antihypertensive activities of Atenolol.
MalathionMalathion may increase the bradycardic activities of Atenolol.
ManidipineAtenolol may increase the hypotensive activities of Manidipine.
MannitolThe risk or severity of adverse effects can be increased when Atenolol is combined with Mannitol.
MaprotilineThe serum concentration of Atenolol can be increased when it is combined with Maprotiline.
MasoprocolMasoprocol may decrease the antihypertensive activities of Atenolol.
MebanazineMebanazine may increase the hypotensive activities of Atenolol.
MebendazoleThe serum concentration of Atenolol can be increased when it is combined with Mebendazole.
MecamylamineAtenolol may increase the hypotensive activities of Mecamylamine.
Meclofenamic acidMeclofenamic acid may decrease the antihypertensive activities of Atenolol.
Mefenamic acidMefenamic acid may decrease the antihypertensive activities of Atenolol.
MefloquineMefloquine may increase the bradycardic activities of Atenolol.
Megestrol acetateThe serum concentration of Atenolol can be increased when it is combined with Megestrol acetate.
MeloxicamMeloxicam may decrease the antihypertensive activities of Atenolol.
MemantineMemantine may increase the bradycardic activities of Atenolol.
MepivacaineThe serum concentration of Mepivacaine can be increased when it is combined with Atenolol.
MeprobamateThe serum concentration of Atenolol can be increased when it is combined with Meprobamate.
MesalazineMesalazine may decrease the antihypertensive activities of Atenolol.
MesoridazineMesoridazine may increase the hypotensive activities of Atenolol.
MetamizoleMetamizole may decrease the antihypertensive activities of Atenolol.
MethacholineThe risk or severity of adverse effects can be increased when Atenolol is combined with Methacholine.
MethadoneThe serum concentration of Atenolol can be increased when it is combined with Methadone.
MethamphetamineMethamphetamine may increase the atrioventricular blocking (AV block) activities of Atenolol.
MethazolamideThe risk or severity of adverse effects can be increased when Atenolol is combined with Methazolamide.
MethohexitalMethohexital may increase the hypotensive activities of Atenolol.
MethotrexateThe serum concentration of Methotrexate can be increased when it is combined with Atenolol.
MethotrimeprazineMethotrimeprazine may increase the hypotensive activities of Atenolol.
MethyclothiazideThe risk or severity of adverse effects can be increased when Methyclothiazide is combined with Atenolol.
MethyldopaAtenolol may increase the hypotensive activities of Methyldopa.
Methylene blueMethylene blue may increase the hypotensive activities of Atenolol.
MethylphenidateMethylphenidate may decrease the antihypertensive activities of Atenolol.
MethylphenobarbitalMethylphenobarbital may increase the hypotensive activities of Atenolol.
MethylprednisoloneThe serum concentration of Methylprednisolone can be increased when it is combined with Atenolol.
MetipranololAtenolol may increase the hypotensive activities of Metipranolol.
MetolazoneAtenolol may increase the hypotensive activities of Metolazone.
MetoprololMetoprolol may increase the hypotensive activities of Atenolol.
MibefradilAtenolol may increase the hypotensive activities of Mibefradil.
MiconazoleThe serum concentration of Atenolol can be increased when it is combined with Miconazole.
MidazolamThe serum concentration of Atenolol can be decreased when it is combined with Midazolam.
MidazolamThe serum concentration of Midazolam can be increased when it is combined with Atenolol.
MidodrineAtenolol may increase the bradycardic activities of Midodrine.
MifepristoneThe serum concentration of Atenolol can be decreased when it is combined with Mifepristone.
MilnacipranThe serum concentration of Atenolol can be increased when it is combined with Milnacipran.
MinaprineMinaprine may increase the bradycardic activities of Atenolol.
MinoxidilAtenolol may increase the hypotensive activities of Minoxidil.
MirabegronThe serum concentration of Mirabegron can be increased when it is combined with Atenolol.
MitomycinThe serum concentration of Atenolol can be increased when it is combined with Mitomycin.
MitoxantroneThe serum concentration of Atenolol can be decreased when it is combined with Mitoxantrone.
MitoxantroneThe serum concentration of Mitoxantrone can be increased when it is combined with Atenolol.
MoclobemideMoclobemide may increase the hypotensive activities of Atenolol.
MoexiprilAtenolol may increase the hypotensive activities of Moexipril.
MolsidomineMolsidomine may increase the hypotensive activities of Atenolol.
MoricizineMoricizine may increase the hypotensive activities of Atenolol.
MorphineThe serum concentration of Morphine can be increased when it is combined with Atenolol.
MoxonidineAtenolol may increase the hypotensive activities of Moxonidine.
Mycophenolate mofetilMycophenolate mofetil may decrease the antihypertensive activities of Atenolol.
Mycophenolate mofetilThe serum concentration of Mycophenolate mofetil can be increased when it is combined with Atenolol.
Mycophenolic acidMycophenolic acid may decrease the antihypertensive activities of Atenolol.
NabumetoneNabumetone may decrease the antihypertensive activities of Atenolol.
NadololAtenolol may increase the hypotensive activities of Nadolol.
NaftifineNaftifine may decrease the antihypertensive activities of Atenolol.
NaloxegolThe serum concentration of Naloxegol can be increased when it is combined with Atenolol.
NaloxoneThe serum concentration of Naloxone can be increased when it is combined with Atenolol.
NaltrexoneThe serum concentration of Atenolol can be increased when it is combined with Naltrexone.
NaphazolineNaphazoline may increase the atrioventricular blocking (AV block) activities of Atenolol.
NaproxenNaproxen may decrease the antihypertensive activities of Atenolol.
NaringeninThe serum concentration of Atenolol can be increased when it is combined with Naringenin.
NCX 4016NCX 4016 may decrease the antihypertensive activities of Atenolol.
NebivololAtenolol may increase the hypotensive activities of Nebivolol.
NefazodoneThe serum concentration of Atenolol can be decreased when it is combined with Nefazodone.
NelfinavirThe serum concentration of Atenolol can be decreased when it is combined with Nelfinavir.
NelfinavirThe serum concentration of Nelfinavir can be increased when it is combined with Atenolol.
NeostigmineNeostigmine may increase the bradycardic activities of Atenolol.
NepafenacNepafenac may decrease the antihypertensive activities of Atenolol.
NesiritideThe risk or severity of adverse effects can be increased when Atenolol is combined with Nesiritide.
NialamideNialamide may increase the hypotensive activities of Atenolol.
NicardipineAtenolol may increase the hypotensive activities of Nicardipine.
NicorandilNicorandil may increase the hypotensive activities of Atenolol.
NicotineThe risk or severity of adverse effects can be increased when Atenolol is combined with Nicotine.
Nicotine bitartrateThe risk or severity of adverse effects can be increased when Atenolol is combined with Nicotine bitartrate.
NifedipineNifedipine may increase the hypotensive activities of Atenolol.
NifedipineThe risk or severity of adverse effects can be increased when Atenolol is combined with Nifedipine.
Niflumic AcidNiflumic Acid may decrease the antihypertensive activities of Atenolol.
NiguldipineAtenolol may increase the hypotensive activities of Niguldipine.
NilotinibThe serum concentration of Nilotinib can be increased when it is combined with Atenolol.
NilvadipineAtenolol may increase the hypotensive activities of Nilvadipine.
NimesulideNimesulide may decrease the antihypertensive activities of Atenolol.
NimodipineAtenolol may increase the hypotensive activities of Nimodipine.
NintedanibThe serum concentration of Nintedanib can be increased when it is combined with Atenolol.
NisoldipineAtenolol may increase the hypotensive activities of Nisoldipine.
NitrazepamThe serum concentration of Atenolol can be increased when it is combined with Nitrazepam.
NitrendipineAtenolol may increase the hypotensive activities of Nitrendipine.
NitroglycerinThe risk or severity of adverse effects can be increased when Atenolol is combined with Nitroglycerin.
NitroprussideNitroprusside may increase the hypotensive activities of Atenolol.
NizatidineThe serum concentration of Nizatidine can be increased when it is combined with Atenolol.
NorepinephrineNorepinephrine may increase the atrioventricular blocking (AV block) activities of Atenolol.
NorepinephrineAtenolol may decrease the bronchodilatory activities of Norepinephrine.
NorethisteroneThe serum concentration of Atenolol can be decreased when it is combined with Norethisterone.
ObinutuzumabAtenolol may increase the hypotensive activities of Obinutuzumab.
OctamoxinOctamoxin may increase the hypotensive activities of Atenolol.
OctreotideOctreotide may increase the bradycardic activities of Atenolol.
OlanzapineThe serum concentration of Atenolol can be increased when it is combined with Olanzapine.
OlmesartanOlmesartan may increase the hypotensive activities of Atenolol.
OlodaterolAtenolol may decrease the bronchodilatory activities of Olodaterol.
OlopatadineOlopatadine may decrease the antihypertensive activities of Atenolol.
OlsalazineOlsalazine may decrease the antihypertensive activities of Atenolol.
OmapatrilatAtenolol may increase the hypotensive activities of Omapatrilat.
OmbitasvirThe serum concentration of Ombitasvir can be increased when it is combined with Atenolol.
OmeprazoleThe serum concentration of Atenolol can be increased when it is combined with Omeprazole.
OrciprenalineAtenolol may decrease the bronchodilatory activities of Orciprenaline.
OrgoteinOrgotein may decrease the antihypertensive activities of Atenolol.
OsimertinibThe serum concentration of Osimertinib can be increased when it is combined with Atenolol.
OuabainAtenolol may increase the bradycardic activities of Ouabain.
OxaprozinOxaprozin may decrease the antihypertensive activities of Atenolol.
OxprenololAtenolol may increase the hypotensive activities of Oxprenolol.
OxymetazolineOxymetazoline may increase the atrioventricular blocking (AV block) activities of Atenolol.
OxyphenbutazoneOxyphenbutazone may decrease the antihypertensive activities of Atenolol.
P-NitrophenolThe serum concentration of Atenolol can be increased when it is combined with P-Nitrophenol.
PaclitaxelThe serum concentration of Atenolol can be increased when it is combined with Paclitaxel.
PaliperidonePaliperidone may increase the atrioventricular blocking (AV block) activities of Atenolol.
Palmitic AcidThe serum concentration of Atenolol can be increased when it is combined with Palmitic Acid.
PanobinostatThe serum concentration of Panobinostat can be increased when it is combined with Atenolol.
PantoprazoleThe serum concentration of Atenolol can be increased when it is combined with Pantoprazole.
PapaverineThe risk or severity of adverse effects can be increased when Atenolol is combined with Papaverine.
ParecoxibParecoxib may decrease the antihypertensive activities of Atenolol.
PargylineAtenolol may increase the hypotensive activities of Pargyline.
ParoxetineThe serum concentration of Atenolol can be increased when it is combined with Paroxetine.
PasireotideAtenolol may increase the bradycardic activities of Pasireotide.
PazopanibThe serum concentration of Pazopanib can be increased when it is combined with Atenolol.
PenbutololAtenolol may increase the hypotensive activities of Penbutolol.
PentobarbitalPentobarbital may increase the hypotensive activities of Atenolol.
PentoliniumAtenolol may increase the hypotensive activities of Pentolinium.
PentoxifyllinePentoxifylline may increase the hypotensive activities of Atenolol.
PergolidePergolide may increase the atrioventricular blocking (AV block) activities of Atenolol.
PerindoprilAtenolol may increase the hypotensive activities of Perindopril.
PerphenazinePerphenazine may increase the hypotensive activities of Atenolol.
PhenelzinePhenelzine may increase the hypotensive activities of Atenolol.
PheniprazinePheniprazine may increase the hypotensive activities of Atenolol.
PhenobarbitalPhenobarbital may increase the hypotensive activities of Atenolol.
PhenobarbitalThe serum concentration of Phenobarbital can be increased when it is combined with Atenolol.
PhenoxybenzamineAtenolol may increase the hypotensive activities of Phenoxybenzamine.
PhenoxypropazinePhenoxypropazine may increase the hypotensive activities of Atenolol.
PhentolamineAtenolol may increase the hypotensive activities of Phentolamine.
PhenylbutazonePhenylbutazone may decrease the antihypertensive activities of Atenolol.
PhenylpropanolaminePhenylpropanolamine may increase the atrioventricular blocking (AV block) activities of Atenolol.
PhenylpropanolamineAtenolol may decrease the bronchodilatory activities of Phenylpropanolamine.
PhenytoinThe serum concentration of Phenytoin can be increased when it is combined with Atenolol.
PhysostigminePhysostigmine may increase the bradycardic activities of Atenolol.
PilocarpineThe risk or severity of adverse effects can be increased when Atenolol is combined with Pilocarpine.
PimecrolimusPimecrolimus may decrease the antihypertensive activities of Atenolol.
PimozideThe serum concentration of Atenolol can be increased when it is combined with Pimozide.
PinacidilAtenolol may increase the hypotensive activities of Pinacidil.
PindololAtenolol may increase the hypotensive activities of Pindolol.
PirbuterolAtenolol may decrease the bronchodilatory activities of Pirbuterol.
PirfenidonePirfenidone may decrease the antihypertensive activities of Atenolol.
PirlindolePirlindole may increase the hypotensive activities of Atenolol.
PiroxicamPiroxicam may decrease the antihypertensive activities of Atenolol.
PitavastatinThe serum concentration of Pitavastatin can be increased when it is combined with Atenolol.
PivhydrazinePivhydrazine may increase the hypotensive activities of Atenolol.
Platelet Activating FactorThe serum concentration of Atenolol can be decreased when it is combined with Platelet Activating Factor.
PolythiazideAtenolol may increase the hypotensive activities of Polythiazide.
PomalidomideThe serum concentration of Pomalidomide can be increased when it is combined with Atenolol.
PonatinibThe serum concentration of Ponatinib can be increased when it is combined with Atenolol.
Poractant alfaAtenolol may increase the bradycardic activities of Poractant alfa.
PosaconazoleThe serum concentration of Atenolol can be increased when it is combined with Posaconazole.
PravastatinThe serum concentration of Pravastatin can be increased when it is combined with Atenolol.
PrazosinAtenolol may increase the hypotensive activities of Prazosin.
PrednisoloneThe serum concentration of Prednisolone can be increased when it is combined with Atenolol.
PrednisoneThe serum concentration of Prednisone can be increased when it is combined with Atenolol.
PrimaquineThe metabolism of Atenolol can be decreased when combined with Primaquine.
PrimidonePrimidone may increase the hypotensive activities of Atenolol.
ProbenecidThe serum concentration of Atenolol can be increased when it is combined with Probenecid.
ProcaterolAtenolol may decrease the bronchodilatory activities of Procaterol.
ProchlorperazineProchlorperazine may increase the hypotensive activities of Atenolol.
ProgesteroneThe serum concentration of Atenolol can be decreased when it is combined with Progesterone.
ProgesteroneThe serum concentration of Progesterone can be increased when it is combined with Atenolol.
PromazinePromazine may increase the hypotensive activities of Atenolol.
PromethazinePromethazine may increase the hypotensive activities of Atenolol.
PropacetamolPropacetamol may decrease the antihypertensive activities of Atenolol.
PropafenoneThe serum concentration of Atenolol can be increased when it is combined with Propafenone.
PropafenoneAtenolol may increase the bradycardic activities of Propafenone.
PropranololAtenolol may increase the hypotensive activities of Propranolol.
ProtriptylineThe serum concentration of Atenolol can be increased when it is combined with Protriptyline.
PrucaloprideThe serum concentration of Prucalopride can be increased when it is combined with Atenolol.
PseudoephedrinePseudoephedrine may increase the atrioventricular blocking (AV block) activities of Atenolol.
PTC299PTC299 may decrease the antihypertensive activities of Atenolol.
PyridostigminePyridostigmine may increase the bradycardic activities of Atenolol.
QuercetinThe serum concentration of Atenolol can be increased when it is combined with Quercetin.
QuetiapineThe risk or severity of adverse effects can be increased when Atenolol is combined with Quetiapine.
QuinacrineThe serum concentration of Atenolol can be increased when it is combined with Quinacrine.
QuinaprilAtenolol may increase the hypotensive activities of Quinapril.
QuinidineThe serum concentration of Atenolol can be increased when it is combined with Quinidine.
QuinineQuinine may increase the hypotensive activities of Atenolol.
QuinineThe serum concentration of Quinine can be increased when it is combined with Atenolol.
RamiprilRamipril may increase the hypotensive activities of Atenolol.
RanitidineThe serum concentration of Atenolol can be increased when it is combined with Ranitidine.
RanolazineThe serum concentration of Ranolazine can be increased when it is combined with Atenolol.
RasagilineRasagiline may increase the hypotensive activities of Atenolol.
ReboxetineThe serum concentration of Atenolol can be increased when it is combined with Reboxetine.
RegorafenibRegorafenib may increase the bradycardic activities of Atenolol.
RemikirenRemikiren may increase the hypotensive activities of Atenolol.
RescinnamineAtenolol may increase the hypotensive activities of Rescinnamine.
ReserpineReserpine may increase the hypotensive activities of Atenolol.
ResveratrolResveratrol may decrease the antihypertensive activities of Atenolol.
RifampicinThe serum concentration of Atenolol can be decreased when it is combined with Rifampicin.
RifampicinThe serum concentration of Rifampicin can be increased when it is combined with Atenolol.
RifaximinThe serum concentration of Rifaximin can be increased when it is combined with Atenolol.
RilpivirineThe serum concentration of Atenolol can be increased when it is combined with Rilpivirine.
RiociguatAtenolol may increase the hypotensive activities of Riociguat.
RisperidoneAtenolol may increase the hypotensive activities of Risperidone.
RisperidoneRisperidone may increase the atrioventricular blocking (AV block) activities of Atenolol.
RitodrineAtenolol may decrease the bronchodilatory activities of Ritodrine.
RitonavirThe serum concentration of Atenolol can be decreased when it is combined with Ritonavir.
RitonavirThe serum concentration of Ritonavir can be increased when it is combined with Atenolol.
RituximabAtenolol may increase the hypotensive activities of Rituximab.
RivaroxabanThe serum concentration of Rivaroxaban can be increased when it is combined with Atenolol.
RivastigmineRivastigmine may increase the bradycardic activities of Atenolol.
RofecoxibRofecoxib may decrease the antihypertensive activities of Atenolol.
RolapitantThe serum concentration of Atenolol can be increased when it is combined with Rolapitant.
RomidepsinThe serum concentration of Romidepsin can be increased when it is combined with Atenolol.
RopiniroleRopinirole may increase the atrioventricular blocking (AV block) activities of Atenolol.
RuxolitinibRuxolitinib may increase the bradycardic activities of Atenolol.
SafrazineSafrazine may increase the hypotensive activities of Atenolol.
SalbutamolAtenolol may decrease the bronchodilatory activities of Salbutamol.
SalicylamideSalicylamide may decrease the antihypertensive activities of Atenolol.
Salicylic acidSalicylic acid may decrease the antihypertensive activities of Atenolol.
Salicylic acidThe serum concentration of Salicylic acid can be increased when it is combined with Atenolol.
SalmeterolAtenolol may decrease the bronchodilatory activities of Salmeterol.
SalsalateSalsalate may decrease the antihypertensive activities of Atenolol.
SaprisartanAtenolol may increase the hypotensive activities of Saprisartan.
SaquinavirThe serum concentration of Atenolol can be decreased when it is combined with Saquinavir.
SaquinavirThe serum concentration of Saquinavir can be increased when it is combined with Atenolol.
ScopolamineThe serum concentration of Atenolol can be increased when it is combined with Scopolamine.
SecobarbitalSecobarbital may increase the hypotensive activities of Atenolol.
SelegilineSelegiline may increase the hypotensive activities of Atenolol.
SelexipagAtenolol may increase the hypotensive activities of Selexipag.
SeratrodastSeratrodast may decrease the antihypertensive activities of Atenolol.
SertralineThe serum concentration of Atenolol can be increased when it is combined with Sertraline.
SildenafilSildenafil may increase the antihypertensive activities of Atenolol.
SilodosinThe serum concentration of Silodosin can be increased when it is combined with Atenolol.
SimeprevirThe serum concentration of Simeprevir can be increased when it is combined with Atenolol.
SimvastatinThe serum concentration of Atenolol can be increased when it is combined with Simvastatin.
SirolimusThe serum concentration of Atenolol can be decreased when it is combined with Sirolimus.
SitagliptinThe serum concentration of Sitagliptin can be increased when it is combined with Atenolol.
SitaxentanAtenolol may increase the hypotensive activities of Sitaxentan.
SofosbuvirThe serum concentration of Sofosbuvir can be increased when it is combined with Atenolol.
SorafenibThe serum concentration of Sorafenib can be increased when it is combined with Atenolol.
SotalolThe risk or severity of adverse effects can be increased when Atenolol is combined with Sotalol.
SparfloxacinThe serum concentration of Sparfloxacin can be increased when it is combined with Atenolol.
SphingosineThe serum concentration of Sphingosine can be increased when it is combined with Atenolol.
SpiraprilAtenolol may increase the hypotensive activities of Spirapril.
SpironolactoneThe risk or severity of adverse effects can be increased when Atenolol is combined with Spironolactone.
SRT501SRT501 may decrease the antihypertensive activities of Atenolol.
St. John's WortThe serum concentration of Atenolol can be decreased when it is combined with St. John's Wort.
StaurosporineThe serum concentration of Atenolol can be increased when it is combined with Staurosporine.
StreptozocinThe serum concentration of Atenolol can be decreased when it is combined with Streptozocin.
SufentanilAtenolol may increase the bradycardic activities of Sufentanil.
SulfasalazineSulfasalazine may decrease the antihypertensive activities of Atenolol.
SulfinpyrazoneThe serum concentration of Atenolol can be increased when it is combined with Sulfinpyrazone.
SulindacSulindac may decrease the antihypertensive activities of Atenolol.
SumatriptanThe serum concentration of Atenolol can be increased when it is combined with Sumatriptan.
SunitinibThe serum concentration of Atenolol can be increased when it is combined with Sunitinib.
SuprofenSuprofen may decrease the antihypertensive activities of Atenolol.
TacrineTacrine may increase the bradycardic activities of Atenolol.
TacrolimusThe serum concentration of Atenolol can be decreased when it is combined with Tacrolimus.
TacrolimusThe serum concentration of Tacrolimus can be increased when it is combined with Atenolol.
TadalafilTadalafil may increase the antihypertensive activities of Atenolol.
TamoxifenThe serum concentration of Atenolol can be decreased when it is combined with Tamoxifen.
TamoxifenThe serum concentration of Tamoxifen can be increased when it is combined with Atenolol.
TamsulosinAtenolol may increase the orthostatic hypotensive activities of Tamsulosin.
Taurocholic AcidThe serum concentration of Taurocholic Acid can be increased when it is combined with Atenolol.
Technetium Tc-99m sestamibiThe serum concentration of Technetium Tc-99m sestamibi can be increased when it is combined with Atenolol.
TelaprevirThe serum concentration of Telaprevir can be increased when it is combined with Atenolol.
TelmisartanAtenolol may increase the hypotensive activities of Telmisartan.
TemocaprilAtenolol may increase the hypotensive activities of Temocapril.
TemsirolimusThe serum concentration of Temsirolimus can be increased when it is combined with Atenolol.
TenoxicamTenoxicam may decrease the antihypertensive activities of Atenolol.
TepoxalinTepoxalin may decrease the antihypertensive activities of Atenolol.
TerazosinThe risk or severity of adverse effects can be increased when Atenolol is combined with Terazosin.
TerbutalineAtenolol may decrease the bronchodilatory activities of Terbutaline.
TerfenadineThe serum concentration of Atenolol can be increased when it is combined with Terfenadine.
TeriflunomideTeriflunomide may decrease the antihypertensive activities of Atenolol.
TerlipressinAtenolol may increase the hypotensive activities of Terlipressin.
TesmilifeneThe serum concentration of Atenolol can be decreased when it is combined with Tesmilifene.
TestosteroneThe serum concentration of Atenolol can be increased when it is combined with Testosterone.
TheophyllineAtenolol may decrease the bronchodilatory activities of Theophylline.
ThiamylalThiamylal may increase the hypotensive activities of Atenolol.
ThiethylperazineThiethylperazine may increase the hypotensive activities of Atenolol.
ThiopentalThiopental may increase the hypotensive activities of Atenolol.
ThioridazineThioridazine may increase the hypotensive activities of Atenolol.
Tiaprofenic acidTiaprofenic acid may decrease the antihypertensive activities of Atenolol.
TiboloneAtenolol may increase the hypotensive activities of Tibolone.
TicagrelorThe serum concentration of Ticagrelor can be increased when it is combined with Atenolol.
TicrynafenAtenolol may increase the hypotensive activities of Ticrynafen.
TimololAtenolol may increase the hypotensive activities of Timolol.
TizanidineThe risk or severity of adverse effects can be increased when Atenolol is combined with Tizanidine.
TofacitinibTofacitinib may increase the bradycardic activities of Atenolol.
TolazamideAtenolol may increase the hypoglycemic activities of Tolazamide.
TolazolineAtenolol may increase the hypotensive activities of Tolazoline.
TolbutamideAtenolol may increase the hypoglycemic activities of Tolbutamide.
Tolfenamic AcidTolfenamic Acid may decrease the antihypertensive activities of Atenolol.
TolmetinTolmetin may decrease the antihypertensive activities of Atenolol.
ToloxatoneToloxatone may increase the hypotensive activities of Atenolol.
TolvaptanThe serum concentration of Tolvaptan can be increased when it is combined with Atenolol.
TopotecanThe serum concentration of Topotecan can be increased when it is combined with Atenolol.
TorasemideTorasemide may increase the hypotensive activities of Atenolol.
ToremifeneThe serum concentration of Toremifene can be increased when it is combined with Atenolol.
TrandolaprilAtenolol may increase the hypotensive activities of Trandolapril.
TranilastTranilast may decrease the antihypertensive activities of Atenolol.
Trans-2-PhenylcyclopropylamineTrans-2-Phenylcyclopropylamine may increase the hypotensive activities of Atenolol.
TranylcypromineTranylcypromine may increase the hypotensive activities of Atenolol.
Trastuzumab emtansineThe serum concentration of Trastuzumab emtansine can be increased when it is combined with Atenolol.
TravoprostTravoprost may increase the hypotensive activities of Atenolol.
TrazodoneThe serum concentration of Atenolol can be increased when it is combined with Trazodone.
TreprostinilAtenolol may increase the hypotensive activities of Treprostinil.
TriamtereneThe risk or severity of adverse effects can be increased when Atenolol is combined with Triamterene.
TrichlorfonTrichlorfon may increase the bradycardic activities of Atenolol.
TrichlormethiazideAtenolol may increase the hypotensive activities of Trichlormethiazide.
TrifluoperazineTrifluoperazine may increase the hypotensive activities of Atenolol.
TriflupromazineTriflupromazine may increase the hypotensive activities of Atenolol.
TrimazosinAtenolol may increase the hypotensive activities of Trimazosin.
TrimethaphanAtenolol may increase the hypotensive activities of Trimethaphan.
TrimethoprimThe serum concentration of Atenolol can be decreased when it is combined with Trimethoprim.
TrimipramineThe serum concentration of Atenolol can be increased when it is combined with Trimipramine.
Trisalicylate-cholineTrisalicylate-choline may decrease the antihypertensive activities of Atenolol.
TroleandomycinThe serum concentration of Atenolol can be increased when it is combined with Troleandomycin.
TubocurarineTubocurarine may increase the bradycardic activities of Atenolol.
UdenafilUdenafil may increase the antihypertensive activities of Atenolol.
UlipristalThe serum concentration of Ulipristal can be increased when it is combined with Atenolol.
UmeclidiniumThe serum concentration of Umeclidinium can be increased when it is combined with Atenolol.
UnoprostoneAtenolol may increase the hypotensive activities of Unoprostone.
ValdecoxibValdecoxib may decrease the antihypertensive activities of Atenolol.
ValsartanValsartan may increase the hypotensive activities of Atenolol.
VardenafilVardenafil may increase the antihypertensive activities of Atenolol.
VareniclineThe risk or severity of adverse effects can be increased when Atenolol is combined with Varenicline.
VecuroniumThe serum concentration of Vecuronium can be increased when it is combined with Atenolol.
VenlafaxineThe serum concentration of Venlafaxine can be increased when it is combined with Atenolol.
VerapamilThe risk or severity of adverse effects can be increased when Atenolol is combined with Verapamil.
VilanterolAtenolol may decrease the bronchodilatory activities of Vilanterol.
VilazodoneThe serum concentration of Atenolol can be increased when it is combined with Vilazodone.
VinblastineThe serum concentration of Atenolol can be decreased when it is combined with Vinblastine.
VinblastineThe serum concentration of Vinblastine can be increased when it is combined with Atenolol.
VincristineThe serum concentration of Vincristine can be increased when it is combined with Atenolol.
VincristineThe serum concentration of Atenolol can be decreased when it is combined with Vincristine.
VinorelbineThe serum concentration of Atenolol can be increased when it is combined with Vinorelbine.
VismodegibThe serum concentration of Vismodegib can be increased when it is combined with Atenolol.
VortioxetineThe serum concentration of Atenolol can be increased when it is combined with Vortioxetine.
XylometazolineAtenolol may increase the hypotensive activities of Xylometazoline.
YohimbineYohimbine may decrease the antihypertensive activities of Atenolol.
ZaltoprofenZaltoprofen may decrease the antihypertensive activities of Atenolol.
ZidovudineThe serum concentration of Zidovudine can be increased when it is combined with Atenolol.
ZileutonZileuton may decrease the antihypertensive activities of Atenolol.
ZimelidineThe serum concentration of Atenolol can be increased when it is combined with Zimelidine.
ZomepiracZomepirac may decrease the antihypertensive activities of Atenolol.
Food Interactions
  • Consult your doctor before taking large amounts of Vitamin K (Green leafy vegetables).
  • Take 30-60 minutes before meals, take at the same time each day.

Targets

Kind
Protein
Organism
Human
Pharmacological action
yes
Actions
antagonist
General Function:
Receptor signaling protein activity
Specific Function:
Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. This receptor binds epinephrine and norepinephrine with approximately equal affinity. Mediates Ras activation through G(s)-alpha- and cAMP-mediated signaling.
Gene Name:
ADRB1
Uniprot ID:
P08588
Molecular Weight:
51322.1 Da
References
  1. Schafer M, Frischkopf K, Taimor G, Piper HM, Schluter KD: Hypertrophic effect of selective beta(1)-adrenoceptor stimulation on ventricular cardiomyocytes from adult rat. Am J Physiol Cell Physiol. 2000 Aug;279(2):C495-503. [PubMed:10913016 ]
  2. Brown RA, Ilg KJ, Chen AF, Ren J: Dietary Mg(2+) supplementation restores impaired vasoactive responses in isolated rat aorta induced by chronic ethanol consumption. Eur J Pharmacol. 2002 May 10;442(3):241-50. [PubMed:12065078 ]
  3. Horinouchi T, Morishima S, Tanaka T, Suzuki F, Tanaka Y, Koike K, Miwa S, Muramatsu I: Different changes of plasma membrane beta-adrenoceptors in rat heart after chronic administration of propranolol, atenolol and bevantolol. Life Sci. 2007 Jul 12;81(5):399-404. Epub 2007 Jun 16. [PubMed:17628611 ]
  4. Alberti C, Monopoli A, Casati C, Forlani A, Sala C, Nador B, Ongini E, Morganti A: Mechanism and pressor relevance of the short-term cardiovascular and renin excitatory actions of the selective A2A-adenosine receptor agonists. J Cardiovasc Pharmacol. 1997 Sep;30(3):320-4. [PubMed:9300315 ]
  5. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
General Function:
Protein homodimerization activity
Specific Function:
Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine.
Gene Name:
ADRB2
Uniprot ID:
P07550
Molecular Weight:
46458.32 Da
References
  1. Nuttall SL, Routledge HC, Kendall MJ: A comparison of the beta1-selectivity of three beta1-selective beta-blockers. J Clin Pharm Ther. 2003 Jun;28(3):179-86. [PubMed:12795776 ]

Transporters

Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrateinhibitor
General Function:
Xenobiotic-transporting atpase activity
Specific Function:
Energy-dependent efflux pump responsible for decreased drug accumulation in multidrug-resistant cells.
Gene Name:
ABCB1
Uniprot ID:
P08183
Molecular Weight:
141477.255 Da
References
  1. Takara K, Kakumoto M, Tanigawara Y, Funakoshi J, Sakaeda T, Okumura K: Interaction of digoxin with antihypertensive drugs via MDR1. Life Sci. 2002 Feb 15;70(13):1491-500. [PubMed:11895100 ]
  2. Neuhoff S, Ungell AL, Zamora I, Artursson P: pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions. Pharm Res. 2003 Aug;20(8):1141-8. [PubMed:12948010 ]
Comments
comments powered by Disqus
Drug created on June 13, 2005 07:24 / Updated on August 17, 2016 12:23